{"content":"<li class=\"n-box-item date-title\" data-end=\"1493179199\" data-start=\"1493092800\" data-txt=\"Monday, December 23, 2019\">Tuesday, April 25, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3259694\" data-ts=\"1493162342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIXI\" target=\"_blank\">ZIXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259694-zixplus-8_5-after-posting-record-results-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zix +8.5% after posting record results in Q1</a></h4><ul>   <li>E-mail security firm Zix (<a href=\"http://seekingalpha.com/symbol/ZIXI\" target=\"_blank\">ZIXI</a> <font color='red'>-2.6%</font>) is one of Nasdaq's top postmarket movers, <font color='green'>up 8.5%</font> after its <a href=\"https://seekingalpha.com/news/3259523-zix-beats-0_01-beats-revenue\" target=\"_blank\">Q1 earnings</a> beat expectations on record revenues and the company boosted 2017 guidance.</li>    <li>EBITDA was $4.46M, up 8.7% and beating an expected $4.15M. Net income grew 8.3% on an adjusted basis.</li>    <li>Total orders fell 9% to $14.3M; meanwhile, backlog rose 4.5% to $78.9M.</li>    <li>For Q2, it's guiding to revenue of $16.1M-$16.4M (up 8-10% Y/Y), vs. consensus for $16.2M, and non-GAAP EPS of $0.06 (light of consensus for $0.07). It's boosting guidance for the full year, for revenues of $66.2M-$66.7M (up 10-11%), above consensus for $65.9M, and EPS of $0.28, above expectations for $0.27.</li>    <li><a href=\"https://seekingalpha.com/pr/16810008-zix-reports-first-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3259694\" data-linked=\"Zix +8.5% after posting record results in Q1\" data-tweet=\"$ZIXI - Zix +8.5% after posting record results in Q1 https://seekingalpha.com/news/3259694-zixplus-8_5-after-posting-record-results-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3259694-zixplus-8_5-after-posting-record-results-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259693\" data-ts=\"1493162331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHT\" target=\"_blank\">DHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259693-frontline-ups-deal-offer-for-rival-dht\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontline ups deal offer for rival DHT</a></h4><ul>     <li>DHT&nbsp;Holdings (NYSE:<a href='https://seekingalpha.com/symbol/DHT' title='DHT Holdings, Inc.'>DHT</a>)&nbsp;<font color='green'>+4.9%</font>&nbsp;AH after Frontline (NYSE:<a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a>) <a href=\"http://www.frontline.bm/external_feed/external_feeds/view/3/press_release/2098776\" target=\"_blank\">proposes a larger merger </a>to include all 11 VLCCs already purchased from BW&nbsp;Group in its takeover offer.</li>     <li>FRO says its offer would be effected at an exchange ratio of 0.8 of its shares for each DHT common share.</li>     <li>FRO says the new proposal represents an 18% premium to DHT's volume weighted average price for the 10 days prior to April 21 and a 15.8% premium to the latest 30-day volume weighted average price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259693\" data-linked=\"Frontline ups deal offer for rival DHT\" data-tweet=\"$DHT $DHT $FRO - Frontline ups deal offer for rival DHT https://seekingalpha.com/news/3259693-frontline-ups-deal-offer-for-rival-dht?source=tweet\" data-url=\"https://seekingalpha.com/news/3259693-frontline-ups-deal-offer-for-rival-dht\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259690\" data-ts=\"1493161133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259690-chipotle-data-breach-pares-gains-from-big-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle data breach pares gains from big earnings beat</a></h4><ul>     <li>Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>), which rose as much as 6.8% after reporting better than expected <a href=\"https://seekingalpha.com/news/3259547-chipotle-mexican-grill-beats-0_33-beats-revenue\" target=\"_blank\">Q1 earnings </a> and its <a href=\"https://seekingalpha.com/news/3259579-chipotle-pops-18-percent-comp\" target=\"_blank\">first increase in same-store sales in more than a year</a>, saw its gains chopped in half when it revealed it had <a href=\"http://www.cnbc.com/2017/04/25/chipotle-mexican-grill-earnings-q1-2017.html\" target=\"_blank\">experienced a data breach</a>; shares now <font color='green'>+2.9%</font>&nbsp;AH.</li>     <li>CMG says it had detected \"unauthorized activity\" on a network that supports payment processing for purchases made at its restaurants, and that it believes it has taken the proper steps to stop the activity.</li>     <li>Although shares pulled back from initial post-earnings gains, InvestorPlace.com's Bret Kenwell believes \"long-term investors have little reason to bail on the stock,\" and that CMG's business should gain momentum throughout 2017 and boost the stock price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259690\" data-linked=\"Chipotle data breach pares gains from big earnings beat\" data-tweet=\"$CMG - Chipotle data breach pares gains from big earnings beat https://seekingalpha.com/news/3259690-chipotle-data-breach-pares-gains-from-big-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3259690-chipotle-data-breach-pares-gains-from-big-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259687\" data-ts=\"1493159703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTI\" target=\"_blank\">ULTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259687-ultimate-software-slips-despite-posting-record-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultimate Software slips despite posting record revenues</a></h4><ul>   <li>Ultimate Software Group (<a href=\"http://seekingalpha.com/symbol/ULTI\" target=\"_blank\">ULTI</a> <font color='green'>+0.5%</font>) is <font color='red'>off 4%</font> in postmarket trading after its <a href=\"https://seekingalpha.com/news/3259598-ultimate-software-group-beats-0_02-misses-revenue\" target=\"_blank\">Q1 earnings</a> beat on the bottom line but narrowly missed revenue expectations.</li>    <li>That's despite revenues rising 22% to a record, and recurring revenues in particular jumping 24% to its own record.</li>    <li>Non-GAAP net income rose to $23M from $21.9M.</li>    <li>Customer retention rate Y/Y was about 96%.</li>    <li>Revenue breakout: Recurring, $189.98M (up 24.4%); Services, $38.5M (up 11.7%).</li>    <li>Cash flows from operations were $46.3M, up from a year-ago $38.6M.</li>    <li>It's guiding to Q2 revenues of $228M, with recurring revenues of about $196M and operating margin of about 20%. For the full year, it expects revenue to grow 24% Y/Y (recurring up 25%) and operating margin of about 21%.</li>    <li><a href=\"https://seekingalpha.com/pr/16809967-ultimate-reports-q1-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3259687\" data-linked=\"Ultimate Software slips despite posting record revenues\" data-tweet=\"$ULTI - Ultimate Software slips despite posting record revenues https://seekingalpha.com/news/3259687-ultimate-software-slips-despite-posting-record-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3259687-ultimate-software-slips-despite-posting-record-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259676\" data-ts=\"1493157344\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKBA\" target=\"_blank\">AKBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259676-akebia-inks-expanded-development-deal-otsuka-for-vadadustat-ex-u-s-valued-high-865m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akebia inks expanded development deal with Otsuka for vadadustat ex-U.S. valued as high as $865M; shares ahead 29% after hours</a></h4><ul><li>Thinly traded micro cap Akebia Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a>) jumps&nbsp;<font color='green'>29%</font>&nbsp;after hours on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16810009-akebia-otsuka-expand-relationship-collaboration-develop-commercialise-vadadustat-europe-china\" target=\"_blank\">announcement</a> that it has expanded its vadadustat collaboration with Otsuka Pharmaceutical (<a href='https://seekingalpha.com/symbol/OTSKY' title='Otsuka Holdings Co. Ltd. ADR'>OTCPK:OTSKY</a>) granting the latter commercialization rights in Europe, China, Russia, Canada, Australia and the Middle East. The companies inked their original deal in December 2016 to co-develop the HIF stabilizer in the U.S.</li><li>Under the terms of the new agreement, Akebia will receive at least $208M in committed capital from Otsuka, including $73M upfront and at least $135M of development funding. Akebia is also eligible to receive up to $657M in milestones and royalties up to 30% on net sales of vadadustat in the territories.</li><li>Akebia inked a collaboration with Mitsubishi Tanabe Pharma for the development and commercialization of vadadustat in Japan, Taiwan, South Korea, Indonesia, India and certain Asian countries in December 2015.</li><li><a href=\"http://akebia.com/programs/akb-6548/\" target=\"_blank\">Vadadustat&nbsp;</a>is an inhibitor of hypoxia inducible factor &#40;HIF&#41;-prolyl hydroxylase, an enzyme that promotes the breakdown of HIF proteins. HIF is the primary regulator of the production of red blood cells. The body's natural response to anemia is to increase the level of HIF proteins. It is being developed for the treatment of anemia related to chronic kidney disease.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3231654-akebia-inks-vadadustat-deal-otsuka-pharma-potentially-valued-1b-shares-32-percent-premarket\" target=\"_blank\">Akebia inks vadadustat deal with Otsuka Pharma potentially valued at $1B; shares up 32% premarket</a> (Dec. 20, 2016)</li><li>Previously: <a href=\"https://seekingalpha.com/news/2981346-akebia-mitsubishi-tanabe-ink-collaboration-deal-vadadustat-asia-akebia-24-percent-premarket\" target=\"_blank\">Akebia and Mitsubishi Tanabe ink collaboration deal for vadadustat in Asia; Akebia up 24% premarket</a> (Dec. 14, 2015)</li></ul><div class=\"tiny-share-widget\" data-id=\"3259676\" data-linked=\"Akebia inks expanded development deal with Otsuka for vadadustat ex-U.S. valued as high as $865M; shares ahead 29% after hours\" data-tweet=\"$AKBA $AKBA $OTSKY - Akebia inks expanded development deal with Otsuka for vadadustat ex-U.S. valued as high as $865M; shares ahead 29% after hours https://seekingalpha.com/news/3259676-akebia-inks-expanded-development-deal-otsuka-for-vadadustat-ex-u-s-valued-high-865m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3259676-akebia-inks-expanded-development-deal-otsuka-for-vadadustat-ex-u-s-valued-high-865m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259668\" data-ts=\"1493156390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXN\" target=\"_blank\">TXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259668-texas-instruments-beats-revenues-grow-13-margins-increase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas Instruments beats as revenues grow 13%, margins increase</a></h4><ul>   <li>Texas Instruments (<a href=\"http://seekingalpha.com/symbol/TXN\" target=\"_blank\">TXN</a> <font color='green'>+1.6%</font>) <a href=\"https://seekingalpha.com/news/3259595-texas-instruments-beats-0_06-beats-revenue\" target=\"_blank\">Q1 results</a> beat expectations with the help of strong demand in the company's automotive market, and building results in the industrial market.</li>    <li>Revenues grew 13%, with Power and Signal Chain gains driving increases in Analog sales of 20%. Operating margins were up both in Analog and in Embedded Processing.</li>    <li>Cash flow from operations was $4.8B; free cash flow for the trailing 12 months was up 11% to $4.2B, making up 30.7% of revenues.</li>    <li>Revenue by segment: Analog, $2.26B (up 20%); Embedded Processing, $803M (up 10%); Other, $343M (down 14%).</li>    <li>Operating profit by segment: Analog, $935M (up 36%); Embedded Processing, $240M (up 28%); Other (including acquisition charges and restructuring charges), $77M (down 29%).</li>    <li><a href=\"https://seekingalpha.com/pr/16810127-ti-reports-1q17-financial-results-shareholder-returns\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3259668\" data-linked=\"Texas Instruments beats as revenues grow 13%, margins increase\" data-tweet=\"$TXN - Texas Instruments beats as revenues grow 13%, margins increase https://seekingalpha.com/news/3259668-texas-instruments-beats-revenues-grow-13-margins-increase?source=tweet\" data-url=\"https://seekingalpha.com/news/3259668-texas-instruments-beats-revenues-grow-13-margins-increase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259667\" data-ts=\"1493156295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLXN\" target=\"_blank\">FLXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259667-flexion-readies-125m-convertible-debt-offering-shares-down-13-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flexion readies $125M convertible debt offering; shares down 13% after hours</a></h4><ul><li>Flexion Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a>) <a href=\"https://seekingalpha.com/pr/16809989-flexion-therapeutics-announces-proposed-convertible-senior-notes-offering\" target=\"_blank\">initiates</a> a private $125M offering of convertible senior notes due 2024 to qualified institutional investors. Net proceeds will fund the commercialization and manufacture of Zilretta, pipeline development, working capital and general corporate purposes. Price, yield and terms have yet to be announced.</li><li>Shares are off&nbsp;<font color='red'>13%</font>&nbsp;after hours on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259667\" data-linked=\"Flexion readies $125M convertible debt offering; shares down 13% after hours\" data-tweet=\"$FLXN - Flexion readies $125M convertible debt offering; shares down 13% after hours https://seekingalpha.com/news/3259667-flexion-readies-125m-convertible-debt-offering-shares-down-13-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3259667-flexion-readies-125m-convertible-debt-offering-shares-down-13-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259666\" data-ts=\"1493156205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259666-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a> <font color='green'>+26.5%</font>. <a href='https://seekingalpha.com/symbol/ZIXI' title='Zix Corporation'>ZIXI</a> <font color='green'>+10.3%</font>. <a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='green'>+9.9%</font>. <a href='https://seekingalpha.com/symbol/AMRI' title='Albany Molecular Research, Inc.'>AMRI</a> <font color='green'>+8.3%</font>. <a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a> <font color='green'>+8.3%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-19.7%</font>. <a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a> <font color='red'>-12.6%</font>. <a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color='red'>-5.7%</font>. <a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a> <font color='red'>-5.1%</font>. <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-4.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259666\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AKBA $ZIXI $IRBT - After Hours Gainers / Losers https://seekingalpha.com/news/3259666-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3259666-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259661\" data-ts=\"1493156021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIX\" target=\"_blank\">NBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259661-neurocrine-readies-convertible-debt-offering-shares-ease-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neurocrine readies convertible debt offering; shares ease 3% after hours</a></h4><ul><li>Neurocrine Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a>) <a href=\"https://seekingalpha.com/pr/16809981-neurocrine-announces-proposed-convertible-senior-notes-offering\" target=\"_blank\">launches </a>a $450M private offering of convertible senior notes due 2024 to qualified institutional investors. Net proceeds will be used for general corporate purposes. Price, yield and terms have yet to be announced.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;after hours on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259661\" data-linked=\"Neurocrine readies convertible debt offering; shares ease 3% after hours\" data-tweet=\"$NBIX - Neurocrine readies convertible debt offering; shares ease 3% after hours https://seekingalpha.com/news/3259661-neurocrine-readies-convertible-debt-offering-shares-ease-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3259661-neurocrine-readies-convertible-debt-offering-shares-ease-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259656\" data-ts=\"1493155636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ILMN\" target=\"_blank\">ILMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259656-illumina-q1-revenues-up-5-earnings-up-313-cash-flow-up-70-conservative-guidance-pressures\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Illumina Q1 revenues up 5%; earnings up 313%; cash flow up 70% ; conservative guidance pressures shares, down 3% after hours</a></h4><ul><li>Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) <a href=\"https://seekingalpha.com/pr/16810032-illumina-reports-financial-results-first-quarter-fiscal-year-2017\" target=\"_blank\">Q1 results</a> ($M): Total Revenues: 598 (+4.5%); Product Revenue: 491 (+1.7%).</li><li>Net Income: 372 (+313.3%); Non-GAAP Net Income: 94 (-11.3%); EPS: 2.52 (+320.0%); Non-GAAP EPS: 0.64 (-9.9%); Cash Flow Ops: 168 (+69.7%).</li><li><strong>2017 Guidance</strong>: Revenue growth: 10 - 12%; EPS: $5.26 - 5.36; Non-GAAP EPS: $3.60 - 3.70.</li><li><strong>Q2 Guidance</strong>: Revenue growth: ~7%; EPS: $0.56 - 0.61; Non-GAAP EPS: $0.65 - 0.70.</li><li>Start-up GRAIL raised over $900M in Series B financing. ILMN's stake now less than 20%.</li><li>Shares are off&nbsp;<font color='red'>3%</font>&nbsp;after hours on modestly higher volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259656\" data-linked=\"Illumina Q1 revenues up 5%; earnings up 313%; cash flow up 70% ; conservative guidance pressures shares, down 3% after hours\" data-tweet=\"$ILMN - Illumina Q1 revenues up 5%; earnings up 313%; cash flow up 70% ; conservative guidance pressures shares, down 3% after hours https://seekingalpha.com/news/3259656-illumina-q1-revenues-up-5-earnings-up-313-cash-flow-up-70-conservative-guidance-pressures?source=tweet\" data-url=\"https://seekingalpha.com/news/3259656-illumina-q1-revenues-up-5-earnings-up-313-cash-flow-up-70-conservative-guidance-pressures\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259628\" data-ts=\"1493153860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259628-u-s-steelminus-17-after-shocking-q1-loss-steel-stocks-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Steel -17% after shocking Q1 loss; other steel stocks lower</a></h4><ul><li>U.S. Steel (NYSE:<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a>) <font color='red'>-17.2%</font>&nbsp;AH after posting an adjusted $0.83/share <a href=\"https://seekingalpha.com/news/3259570-u-s-nbsp-steel-misses-1_15-misses-revenue\" target=\"_blank\">Q1 loss</a> instead of an expected solid gain.</li><li>The company says Q1 results for its flat-rolled segment declined \"significantly\" Q/Q, \"as we expected, primarily due to higher raw   material costs, increased planned outage costs, seasonally lower results  from  our mining operations, and restart costs associated with the  Granite City hot  strip mill and our Keetac iron ore mine.\"</li><li>X says market conditions have continued to improve, and that it \"will realize greater  benefits as these improved conditions are recognized more fully in our future  results.\"</li><li>Other steel stocks are down in sympathy: <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='red'>-2.3%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='red'>-2.8%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-4.2%</font>, <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='red'>-4.4%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='red'>-5.2%</font>&nbsp;AH.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259628\" data-linked=\"U.S. Steel -17% after shocking Q1 loss; other steel stocks lower\" data-tweet=\"$X $X $NUE - U.S. Steel -17% after shocking Q1 loss; other steel stocks lower https://seekingalpha.com/news/3259628-u-s-steelminus-17-after-shocking-q1-loss-steel-stocks-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3259628-u-s-steelminus-17-after-shocking-q1-loss-steel-stocks-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259619\" data-ts=\"1493153425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259619-juniper-networksplus-3_3-cloud-solutions-provide-earnings-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper Networks +3.3% as cloud solutions provide earnings boost</a></h4><ul>   <li>Juniper Networks (<a href=\"http://seekingalpha.com/symbol/JNPR\" target=\"_blank\">JNPR</a> <font color='red'>-1.7%</font>) is <font color='green'>up 3.3%</font> postmarket following <a href=\"https://seekingalpha.com/news/3259583-juniper-networks-beats-0_04-beats-revenue\" target=\"_blank\">Q1 earnings</a> that beat on top and bottom lines, with solid sales growth in Asia Pacific and in cloud products and services.</li>    <li>Net income was up 19% Y/Y on a GAAP basis, and up 25% non-GAAP to $178M.</li>    <li>Cash flow from operations was particularly strong at $545M, vs. a year-ago $172M and last quarter's $335M. days sales outstanding was 49 days, vs. a year-ago 64 days and last quarter's 68 days.</li>    <li>Revenue breakout: Product, $828.9M (up 10.1%); Service, $392.1M (up 13.7%).</li>    <li>For the first time, it's breaking out revenues by vertical: Cloud, $331.6M (up 25.2%); Telecom/Cable, $568.5M (up 9.7%); Strategic Enterprise, $320.9M (up 1.9%).</li>    <li>It's guiding in line to revenues of $1.25B-$1.31B (vs. consensus for $1.28B), non-GAAP gross margin of 62-63%, and EPS of $0.51-$0.57 (vs. $0.53 expected).</li>    <li><a href=\"http://investor.juniper.net/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16810120-juniper-networks-reports-preliminary-first-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3259619\" data-linked=\"Juniper Networks +3.3% as cloud solutions provide earnings boost\" data-tweet=\"$JNPR - Juniper Networks +3.3% as cloud solutions provide earnings boost https://seekingalpha.com/news/3259619-juniper-networksplus-3_3-cloud-solutions-provide-earnings-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3259619-juniper-networksplus-3_3-cloud-solutions-provide-earnings-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259603\" data-ts=\"1493152472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGO\" target=\"_blank\">PRGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259603-perrigo-to-restate-financials-due-to-misclassification-of-tysabri-royalty-stream-and-certain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perrigo to restate financials due to misclassification of Tysabri royalty stream and certain other assets</a></h4><ul><li>Perrigo (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGO' title='Perrigo Company'>PRGO</a>) <a href=\"https://seekingalpha.com/pr/16809997-perrigo-announces-restatement-previously-issued-forms-10-k-10-q-financial-statements\" target=\"_blank\">announces</a> that its financial statements for fiscal 2014, fiscal 2015, the transition period from Jun 28, 2015 to December 31, 2015 and quarters ended December 31, 2013, March 29, 2014, September 27, 2014, December 27, 2014, March 28, 2015, September 26, 2015, April 2, 2016, July 2, 2016 and October 1, 2016 should no longer be relied upon.</li><li>One issue is the accounting treatment of the Tysabri royalty stream, historically recorded as an intangible asset, to be restated as a financial asset.</li><li>Another issue pertains to certain deferred tax assets that existed at the time of the Omega Pharma Invest N.V. acquisition valued at ~$220M. Reclassifying these assets will reduce goodwill, offset by a corresponding reduction in net deferred tax liabilities at the date of the Omega transaction. A further correction is necessary to correct the accounting effect after the acquisition date, including goodwill impairment recorded in fiscal 2016.</li><li>The company says the restatements should not have a material effect on net cash flows and on the previously closed Tysabri deal with RPI Finance Trust.</li><li><strong>2017 Guidance</strong>: Net sales (ex-Tysabri): $4.6B - 4.8B; cash flow ops: greater than $575M.</li><li>Separately, Perrigo has issued a notice of redemption to redeem all $600M of the outstanding 2.300% senior notes due 2018. All of the notes will be retired with cash on hand.</li><li>Management will host a conference call today at 5:00 pm ET to provide a business update.</li><li>Share are unchanged after hours on modest volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259603\" data-linked=\"Perrigo to restate financials due to misclassification of Tysabri royalty stream and certain other assets\" data-tweet=\"$PRGO - Perrigo to restate financials due to misclassification of Tysabri royalty stream and certain other assets https://seekingalpha.com/news/3259603-perrigo-to-restate-financials-due-to-misclassification-of-tysabri-royalty-stream-and-certain?source=tweet\" data-url=\"https://seekingalpha.com/news/3259603-perrigo-to-restate-financials-due-to-misclassification-of-tysabri-royalty-stream-and-certain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259591\" data-ts=\"1493152280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREE\" target=\"_blank\">CREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259591-creeminus-4_9-on-missed-revenues-downside-q4-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cree -4.9% on missed revenues, downside Q4 guidance</a></h4><ul>   <li>Cree (NASDAQ:<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a>) is <font color='red'>off 4.9%</font> in late trading after its <a href=\"https://seekingalpha.com/news/3259519-cree-beats-0_07-misses-revenue\" target=\"_blank\">fiscal Q3 earnings</a> showed revenues that dropped nearly 7% and missed expectations, and featured downside guidance for the out quarter.</li>    <li>The cancellation of its sale of Wolfspeed to Infineon means Q3 included two items that otherwise wouldn't have occurred: an income tax expense charge of $86M and an additional $12M in expenses tied to Wolfspeed's long-lived assets.</li>    <li>Non-GAAP results were otherwise in the company's target range, says CEO Chuck Swoboda. &ldquo;Our Wolfspeed and LED Products businesses performed at or above their targets for the quarter, while Lighting Products came in a little below plan due to softer market conditions and the lingering effects of the third party product driver issue that we mentioned in Q2.\"</li>    <li>Cree also says today that it's forming a joint venture -- Cree Venture LED Co. Ltd. -- with China's San'an Optoelectronics, targeting the production of high-performing, mid-power lighting class LEDs.</li>    <li>It's guiding to fiscal Q4 revenues of $340M-$360M (vs. consensus for $359.5M), and non-GAAP EPS of $0.02-$0.07 (below consensus for $0.14).</li>    <li><a href=\"http://investor.cree.com/events.cfm\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16809996-cree-reports-financial-results-third-quarter-fiscal-year-2017\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3259591\" data-linked=\"Cree -4.9% on missed revenues, downside Q4 guidance\" data-tweet=\"$CREE - Cree -4.9% on missed revenues, downside Q4 guidance https://seekingalpha.com/news/3259591-creeminus-4_9-on-missed-revenues-downside-q4-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3259591-creeminus-4_9-on-missed-revenues-downside-q4-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259588\" data-ts=\"1493152202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COF\" target=\"_blank\">COF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259588-capital-oneminus-4_6-on-miss-credit-metrics-deteriorate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capital One -4.6 on miss; credit metrics deteriorate</a></h4><ul><li>Q1 net income (excl. U.K. PPI Reserve) of $910M or $1.75 per share vs. $1B and $1.84 a year ago.</li><li>Net interest income of $5.474B up 8% Y/Y.</li><li>Noninterest income of $1.061B down 9% Y/Y</li><li>Noninterest expense of $3.424B up 7% Y/Y, with marketing expense of $396M down 7%, and operating expense of $2.976B up 10%.</li><li>Provision for credit losses of $1.992B up 14% from Q4 and 30% Y/Y. Allowance for loan and lease losses of $6.984B up 29% Y/Y; as a percent of loans held for investment of 2.9% up 52 basis points. Net charge-offs of $1.51B up 28%; net charge-off rate of 2.5% up 42 bps. 30-day delinquency rate of 2.92 up 28 bps.</li><li>ROA of 0.90% down 33 basis points Y/Y; ROTCE of 10.37% down 257 bps.</li><li><a href=\"http://www.capitalone.com\" target=\"_blank\">Conference call at 5 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3259540-capital-one-financial-lower-4_2-percent-earnings-miss\" target=\"_blank\">Capital One Financial lower 4.2% on earnings miss</a> (April 25)</li><li><a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a><font color='red'> -4.6%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3259588\" data-linked=\"Capital One -4.6 on miss; credit metrics deteriorate\" data-tweet=\"$COF - Capital One -4.6 on miss; credit metrics deteriorate https://seekingalpha.com/news/3259588-capital-oneminus-4_6-on-miss-credit-metrics-deteriorate?source=tweet\" data-url=\"https://seekingalpha.com/news/3259588-capital-oneminus-4_6-on-miss-credit-metrics-deteriorate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259579\" data-ts=\"1493151959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259579-chipotle-pops-after-18-comp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle pops after 18% comp</a></h4><ul>     <li>Chipotle (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>) reports comparable sales increased 17.8% in <a href=\"https://seekingalpha.com/pr/16810048-chipotle-mexican-grill-inc-announces-first-quarter-2017-results\" target=\"_blank\">Q1</a> vs. +15.5% consensus.</li>     <li>Restaurant-level operating margin jumped to 17.7% vs. 6.8% a year ago.</li>     <li>Food/beverage/packaging costs as a percentage of sales fell 150 bps to 33.8%.</li>     <li>G&amp;A expenses were down 90 bps to 6.5%.</li>     <li>The company ended with a restaurant count of 2,291.</li>     <li>Chipotle says it expects comparable restaurant sales to increase at a high single-digit rate in 2017. The company expects to open between 195 and 210 restaurants this year. 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259547-chipotle-mexican-grill-beats-0_33-beats-revenue\" target=\"_blank\">Chipotle Mexican Grill beats by $0.33, beats on revenue</a> (April 25)</li>     <li>CMG&nbsp;<font color='green'>+4.64%</font>&nbsp;AH to $492.61.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259579\" data-linked=\"Chipotle pops after 18% comp\" data-tweet=\"$CMG - Chipotle pops after 18% comp https://seekingalpha.com/news/3259579-chipotle-pops-after-18-comp?source=tweet\" data-url=\"https://seekingalpha.com/news/3259579-chipotle-pops-after-18-comp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259572\" data-ts=\"1493151727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EW\" target=\"_blank\">EW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259572-edwards-lifesciences-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edwards Lifesciences beats by $0.12, beats on revenue</a></h4><ul><li>Edwards Lifesciences (NYSE:<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a>): Q1 EPS of $0.94 <font color='green'>beats by $0.12</font>.</li><li>Revenue of $884M (+26.8% Y/Y) <font color='green'>beats by $107.3M</font>.</li><li>Shares <font color='green'>+7.7%</font>.</li><li><a href='https://seekingalpha.com/pr/16810077-edwards-lifesciences-reports-first-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259572\" data-linked=\"Edwards Lifesciences beats by $0.12, beats on revenue\" data-tweet=\"$EW - Edwards Lifesciences beats by $0.12, beats on revenue https://seekingalpha.com/news/3259572-edwards-lifesciences-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3259572-edwards-lifesciences-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259569\" data-ts=\"1493151640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSS\" target=\"_blank\">TSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259569-total-system-services-beats-0_05-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Total System Services beats by $0.05, misses on revenue</a></h4><ul><li>Total System Services (NYSE:<a href='https://seekingalpha.com/symbol/TSS' title='Total System Services, Inc.'>TSS</a>): Q1 EPS of $0.82 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $832.89M (+24.0% Y/Y) <font color='red'>misses by $0.95M</font>.</li><li>Shares <font color='green'>+3.76%</font>.</li><li><a href='https://seekingalpha.com/pr/16810085-tsys-reports-first-quarter-earnings'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259569\" data-linked=\"Total System Services beats by $0.05, misses on revenue\" data-tweet=\"$TSS - Total System Services beats by $0.05, misses on revenue https://seekingalpha.com/news/3259569-total-system-services-beats-0_05-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3259569-total-system-services-beats-0_05-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259563\" data-ts=\"1493151541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNC\" target=\"_blank\">ARNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259563-arconic-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arconic beats by $0.09, beats on revenue</a></h4><ul><li>Arconic (NYSE:<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a>): Q1 EPS of $0.33 <font color='green'>beats by $0.09</font>.</li><li>Revenue of $3.2B (+4.9% Y/Y) <font color='green'>beats by $200M</font>.</li><li>Shares <font color='green'>+3.9%</font>.</li><li><a href='https://seekingalpha.com/pr/16810081-arconic-reports-first-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259563\" data-linked=\"Arconic beats by $0.09, beats on revenue\" data-tweet=\"$ARNC - Arconic beats by $0.09, beats on revenue https://seekingalpha.com/news/3259563-arconic-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3259563-arconic-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259557\" data-ts=\"1493151416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259557-wynn-resorts-gains-after-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn Resorts gains after profit beat</a></h4><ul>     <li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) <font color='green'>shoots up 3.54%</font>&nbsp;in AH trading after Q1 adjusted property EBITDA tops estimates, $$28M vs. $376M.</li>     <li>Wynn Palace generated $476M of revenue during the quarter to help offset lower levels from other properties, while Las Vegas properties generated $413M. The cccupancy rate in Vegas soared to 85.5% vs. 81.7% a year ago. REVPAR was up 11% to $269.</li>     <li>Revenue from Wynn Macau was down 3.5% Y/Y $587M. Adjusted property EBITDA from Wynn Macau was down 5% to $181M.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3259534-wynn-resorts-beats-0_27-beats-revenue\" target=\"_blank\">Wynn Resorts beats by $0.27, beats on revenue</a> (April 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259557\" data-linked=\"Wynn Resorts gains after profit beat\" data-tweet=\"$WYNN - Wynn Resorts gains after profit beat https://seekingalpha.com/news/3259557-wynn-resorts-gains-after-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3259557-wynn-resorts-gains-after-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259547\" data-ts=\"1493151100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259547-chipotle-mexican-grill-beats-0_33-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle Mexican Grill beats by $0.33, beats on revenue</a></h4><ul><li>Chipotle Mexican Grill (NYSE:<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a>): Q1 EPS of $1.60 <font color='green'>beats by $0.33</font>.</li><li>Revenue of $1.07B (+28.2% Y/Y) <font color='green'>beats by $20M</font>.</li><li>Shares <font color='green'>+4.71%</font>.</li><li><a href='https://seekingalpha.com/pr/16810048-chipotle-mexican-grill-inc-announces-first-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259547\" data-linked=\"Chipotle Mexican Grill beats by $0.33, beats on revenue\" data-tweet=\"$CMG - Chipotle Mexican Grill beats by $0.33, beats on revenue https://seekingalpha.com/news/3259547-chipotle-mexican-grill-beats-0_33-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3259547-chipotle-mexican-grill-beats-0_33-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259546\" data-ts=\"1493151070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPW\" target=\"_blank\">MPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259546-medical-properties-trust-down-2-on-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medical Properties Trust down 2% on secondary offering</a></h4><ul><li>The <a href=\"https://seekingalpha.com/pr/16810014-medical-properties-trust-announces-public-offering-37500-000-shares-common-stock\" target=\"_blank\">company is raising equity capital</a> to help fund its purchase of eight hospitals from Steward Health Care System, the purchase of two acute care hospitals from Alecto Healthcare, and two other acquisitions.</li><li>Being sold are 37.5M shares, with an underwriter greenshoe for up to another 5.625M shares. Goldman, BofA, and KeyBanc are the underwriters.</li><li><a href='https://seekingalpha.com/symbol/MPW' title='Medical Properties Trust, Inc.'>MPW</a>&nbsp;<font color='red'>-2%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3259546\" data-linked=\"Medical Properties Trust down 2% on secondary offering\" data-tweet=\"$MPW - Medical Properties Trust down 2% on secondary offering https://seekingalpha.com/news/3259546-medical-properties-trust-down-2-on-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3259546-medical-properties-trust-down-2-on-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259541\" data-ts=\"1493150974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNRA\" target=\"_blank\">PNRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259541-pricing-and-traffic-up-panera-bread\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pricing and traffic up at Panera Bread</a></h4><ul>     <li>Panera Bread (NASDAQ:<a href='https://seekingalpha.com/symbol/PNRA' title='Panera Bread Company'>PNRA</a>)&nbsp;reports comparable bakery-cafe sales increased 5.3% in <a href=\"https://seekingalpha.com/pr/16809984-panera-bread-company-reports-q1-2017-results\" target=\"_blank\">Q1</a> at company-operated stores. Total comparable sales growth came in at +2.6%, level with the consensus estimate.</li>     <li>Pricing was up 2% and transactions were 1.7% higher.</li><li>Digital sales accounted for 26% of sales during the quarter.</li>     <li>Cost of food and paper products -110 bps to 28.4% of sales.</li>     <li>Labor costs +140 bps to 33.4% of sales.</li>     <li>Operating profit rate +150 bps to 9.8%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259518-panera-bread-eps-line-beats-revenue\" target=\"_blank\">Panera Bread EPS in-line, beats on revenue</a> (April 25)</li>     <li>PNRA&nbsp;<font color='red'>-0.44%</font>&nbsp;after hours to $312.35.</li>       </ul><div class=\"tiny-share-widget\" data-id=\"3259541\" data-linked=\"Pricing and traffic up at Panera Bread\" data-tweet=\"$PNRA - Pricing and traffic up at Panera Bread https://seekingalpha.com/news/3259541-pricing-and-traffic-up-panera-bread?source=tweet\" data-url=\"https://seekingalpha.com/news/3259541-pricing-and-traffic-up-panera-bread\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259534\" data-ts=\"1493150839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259534-wynn-resorts-beats-0_27-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wynn Resorts beats by $0.27, beats on revenue</a></h4><ul><li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>): Q1 EPS of $1.24 <font color='green'>beats by $0.27</font>.</li><li>Revenue of $1.48B (+48.3% Y/Y) <font color='green'>beats by $100M</font>.</li><li>Shares <font color='green'>+3.93%</font>.</li><li><a href='https://seekingalpha.com/pr/16810024-wynn-resorts-limited-reports-first-quarter-2017-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259534\" data-linked=\"Wynn Resorts beats by $0.27, beats on revenue\" data-tweet=\"$WYNN - Wynn Resorts beats by $0.27, beats on revenue https://seekingalpha.com/news/3259534-wynn-resorts-beats-0_27-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3259534-wynn-resorts-beats-0_27-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259522\" data-ts=\"1493150738\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALGT\" target=\"_blank\">ALGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259522-allegiant-travel-company-misses-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegiant Travel Company misses by $0.06, beats on revenue</a></h4><ul><li>Allegiant Travel Company (NASDAQ:<a href='https://seekingalpha.com/symbol/ALGT' title='Allegiant Travel Company'>ALGT</a>): Q1 EPS of $2.50 <font color='red'>misses by $0.06</font>.</li><li>Revenue of $375.84M (+7.8% Y/Y) <font color='green'>beats by $0.89M</font>.</li><li>Shares <font color='green'>+1.34%</font>.</li><li><a href='https://seekingalpha.com/pr/16809988-allegiant-travel-company-first-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259522\" data-linked=\"Allegiant Travel Company misses by $0.06, beats on revenue\" data-tweet=\"$ALGT - Allegiant Travel Company misses by $0.06, beats on revenue https://seekingalpha.com/news/3259522-allegiant-travel-company-misses-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3259522-allegiant-travel-company-misses-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259521\" data-ts=\"1493150711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRCY\" target=\"_blank\">MRCY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259521-mercury-systems-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercury Systems beats by $0.12, beats on revenue</a></h4><ul><li>Mercury Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MRCY' title='Mercury Systems, Inc.'>MRCY</a>): Q1 EPS of $0.29 <font color='green'>beats by $0.12</font>.</li><li>Revenue of $107.31M (+62.8% Y/Y) <font color='green'>beats by $1.77M</font>.</li><li>Shares <font color='green'>+4%</font>.</li><li><a href='https://seekingalpha.com/pr/16809985-mercury-systems-reports-record-third-quarter-results-increases-annual-guidance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259521\" data-linked=\"Mercury Systems beats by $0.12, beats on revenue\" data-tweet=\"$MRCY - Mercury Systems beats by $0.12, beats on revenue https://seekingalpha.com/news/3259521-mercury-systems-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3259521-mercury-systems-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259697\" data-ts=\"1493150116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXU\" target=\"_blank\">LXU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259697-lsb-industriesplus-30-quarterly-results-continue-improvement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LSB Industries +30% as quarterly results continue improvement</a></h4><ul>     <li>LSB&nbsp;Industries (<a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='green'>+30.7%</font>) soars 30% after reporting a narrower <a href=\"https://seekingalpha.com/news/3259064-lsb-industries-eps-line-beats-revenue\" target=\"_blank\">Q1 loss</a> of $6M compared to a $14.9M loss in the year-ago quarter, on 24% higher revenues.</li><li>LSB reported higher Q1 net sales of agricultural products, driven by respective sales  volume increases for ammonia, UAN and HDAN of 21%, 67% and  67%, resulting from a healthier demand environment relative than a year ago when there was excess inventory in the distribution channel and  customers were reluctant to place orders due to a declining price  environment.</li><li>LSB says performance at its troubled chemical plants also <a href=\"http://newsok.com/lsb-industries-narrows-first-quarter-loss/article/5546705\" target=\"_blank\">improved</a>, as the Cherokee and Pryor ammonia plants operated at respective onstream rates of 99% and 96% throughout the quarter and have continued their strong performance in  April, while El Dorado's Q1 ammonia onstream rate rose to 90% and to 100% for the month of March.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3259697\" data-linked=\"LSB Industries +30% as quarterly results continue improvement\" data-tweet=\"$LXU - LSB Industries +30% as quarterly results continue improvement https://seekingalpha.com/news/3259697-lsb-industriesplus-30-quarterly-results-continue-improvement?source=tweet\" data-url=\"https://seekingalpha.com/news/3259697-lsb-industriesplus-30-quarterly-results-continue-improvement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259508\" data-ts=\"1493149910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259508-t-mobileplus-2-analysts-boost-targets-on-growth-m-prospects\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile +2% as analysts boost targets on growth, M&amp;A prospects</a></h4><ul>   <li>T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) is <font color='green'>up 2%</font> today and setting a new 52-week high after <a href=\"https://seekingalpha.com/news/3259112-t-mobile-adds-net-1m-customers-grows-revenues-12-percent\" target=\"_blank\">yesterday's earnings report</a> showed more market share growth, and analyst eyes turned toward future gains and potential M&amp;A activity, with an industry quiet period wrapping up tomorrow.</li>    <li>Several boosted price targets: Oppenheimer raised its to $75 from $70, implying near-14% upside from yesterday's close. Meanwhile, Cowen raised its target to $70 from $67, and Pacific Crest went to $72 from $70.</li>    <li>Cowen's Colby Synesael suggests T-Mobile could be part of acquisition talk either as a buyer or a seller, with \"everything on the table.\" And Macquarie's Amy Yong says management seemed clear on its call that mobile Internet will drive M&amp;A with a convergence between wireline and wireless. She's set a price target of $67, up from $65.</li>    <li>Oppenheimer's Tim Horan says T-Mobile is still attractive on a stand-alone basis, without merging with Sprint or another partner.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259508\" data-linked=\"T-Mobile +2% as analysts boost targets on growth, M&amp;A prospects\" data-tweet=\"$TMUS - T-Mobile +2% as analysts boost targets on growth, M&amp;A prospects https://seekingalpha.com/news/3259508-t-mobileplus-2-analysts-boost-targets-on-growth-m-prospects?source=tweet\" data-url=\"https://seekingalpha.com/news/3259508-t-mobileplus-2-analysts-boost-targets-on-growth-m-prospects\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259507\" data-ts=\"1493149786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LH\" target=\"_blank\">LH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259507-labcorp-extends-process-improvement-initiative-to-covance-30m-charge-planned-to-cover-costs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LabCorp extends process improvement initiative to Covance, $30M charge planned to cover costs associated with job cuts and facility closures; shares slip 4%</a></h4><ul><li>Laboratory Corporation of America Holdings (<a href='https://seekingalpha.com/symbol/LH' title='Laboratory Corporation of America Holdings'>LH</a> <font color='red'>-3.7%</font>) <a href=\"https://seekingalpha.com/filing/3513779\" target=\"_blank\">plans to expand </a>its LaunchPad business process improvement initiative to its Covance Drug Development unit. The two-phase plan will be implemented over three years.</li><li>The aim of the first phase is to better align Covance's resources with its near-term outlook, an action that will result in job cuts this year. The company says it will save ~$20M pretax in 2017 and ~$45M each year thereafter with a reduction in workforce and closure of certain facilities. It plans to record a total charge of $30M this year to cover severance costs and expenses associated with shuttering the sites.</li><li>The second phase will focus on long-term structural changes designed to create a more efficient business model. Additional details will be provided later this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259507\" data-linked=\"LabCorp extends process improvement initiative to Covance, $30M charge planned to cover costs associated with job cuts and facility closures; shares slip 4%\" data-tweet=\"$LH - LabCorp extends process improvement initiative to Covance, $30M charge planned to cover costs associated with job cuts and facility closures; shares slip 4% https://seekingalpha.com/news/3259507-labcorp-extends-process-improvement-initiative-to-covance-30m-charge-planned-to-cover-costs?source=tweet\" data-url=\"https://seekingalpha.com/news/3259507-labcorp-extends-process-improvement-initiative-to-covance-30m-charge-planned-to-cover-costs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259509\" data-ts=\"1493149678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LMT\" target=\"_blank\">LMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259509-lockheed-martin-dinged-nearly-200m-in-middle-east-charges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lockheed Martin dinged by nearly $200M in Middle East charges</a></h4><ul>     <li>Lockheed Martin (<a href='https://seekingalpha.com/symbol/LMT' title='Lockheed Martin'>LMT</a> <font color='red'>-2.2%</font>) says it <a href=\"http://www.marketwatch.com/story/lockheed-martin-hit-by-middle-east-charges-2017-04-25\" target=\"_blank\">booked $184M in charges</a> on two Middle East contracts, in a move that highlights the potential pitfalls of the overseas deals that have been driving growth for U.S. defense contractors.</li>     <li>LMT took charges on a new missile-defense system being developed for the UAE and an Abu Dhabi-based aircraft maintenance joint venture, ending a multi-quarter run of earnings beats.</li>     <li>In today's earnings conference call, LMT&nbsp;CEO Marillyn Hewson acknowledged the dent to  the company's <a href=\"https://seekingalpha.com/news/3259260-lockheed-martin-misses-0_18-misses-revenue\" target=\"_blank\">Q1 earnings</a> but said she remained optimistic both ventures could still trigger future sales growth.</li>     <li>LMT says it still expects profit margins on its critical F-35 combat jet to continue rising, even as it pursues an effort to cut the cost of the most popular model to $80M each over the next several years; the F-35 is central to the company's growth plans, and a follow-on  multiyear deal for 440 jets could be worth more than $30B, one of  the largest-ever defense sales.</li><li>Shares are lower today, after reaching an all-time high yesterday of $276.64.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259509\" data-linked=\"Lockheed Martin dinged by nearly $200M in Middle East charges\" data-tweet=\"$LMT - Lockheed Martin dinged by nearly $200M in Middle East charges https://seekingalpha.com/news/3259509-lockheed-martin-dinged-nearly-200m-in-middle-east-charges?source=tweet\" data-url=\"https://seekingalpha.com/news/3259509-lockheed-martin-dinged-nearly-200m-in-middle-east-charges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259500\" data-ts=\"1493148705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTM\" target=\"_blank\">ANTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259500-all-eyes-on-anthem-ahead-of-q1-earnings-release-tomorrow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">All eyes on Anthem ahead of Q1 earnings release tomorrow</a></h4><ul><li>Anthem's (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color='green'>+2.4%</font>) premarket release of Q1 results tomorrow is drawing an inordinate amount of interest following Express Scripts' disclosure that its contract with the health insurer will not be renewed beyond 2019.</li><li>Consensus view for the quarter is non-GAAP EPS of $3.86 on revenues of $21.3B (Yahoo Finance). On March 15, the company <a href=\"https://seekingalpha.com/filing/3460723\" target=\"_blank\">announced </a>that it expects to earn at least $11.11 per share for the year.</li><li>JPMorgan says a contract extension with ESRX would be preferable considering the cost and disruption of switching its PBM, unless it can get better pricing from CVS or OptumRx. Anthem has declared to the market that it overpays by $3B per year compared to prevailing market rates. In addition, it appears that ESRX could dip further into the annual savings well ($1.35B compared to the $1B that it has offered) if it elects to do so. Assuming a 20% flow-through to shareholders, a revised bid could add $0.61 to earnings, which could double in 2020 if EBITDA/script falls to the $1.50 - 2.00 range which Aetna is believed to be earning under its contract with CVS.</li><li>Stifel says ANTM is \"locking itself into a disadvantaged position\" by refusing to negotiate with ESRX which could pressure shares.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3259500\" data-linked=\"All eyes on Anthem ahead of Q1 earnings release tomorrow\" data-tweet=\"$ANTM - All eyes on Anthem ahead of Q1 earnings release tomorrow https://seekingalpha.com/news/3259500-all-eyes-on-anthem-ahead-of-q1-earnings-release-tomorrow?source=tweet\" data-url=\"https://seekingalpha.com/news/3259500-all-eyes-on-anthem-ahead-of-q1-earnings-release-tomorrow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259494\" data-ts=\"1493146813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259494-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HSTM' title='HealthStream, Inc.'>HSTM</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/BITA' title='Bitauto Holdings Limited'>BITA</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/POLA' title='Polar Power Inc'>POLA</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='red'>-7%</font>. COOL <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/HIMX' title='Himax Technologies, Inc.'>HIMX</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NCTY' title='The9 Limited'>NCTY</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259494\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$HSTM $STRP $ICHR - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3259494-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3259494-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259495\" data-ts=\"1493146560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUN\" target=\"_blank\">SUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259495-sunoco-upgraded-citi-on-best-deal-team-in-game\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunoco upgraded at Citi on &quot;best deal team in the game&quot;</a></h4><ul>     <li>Sunoco LP (<a href='https://seekingalpha.com/symbol/SUN' title='Sunoco LP'>SUN</a> <font color='green'>+1.8%</font>) is higher after Citigroup <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9340245/sunoco-boasts-best-deal-team-in-the-game-citi-upgrades\" target=\"_blank\">upgrades</a> shares to Neutral from Sell with a $29 price target, raised from $22, saying SUN's management team has proven to be \"the best deal team in the game\" in its space.</li>     <li>Citi analyst Faisel Khan lauds the deal SUN struck with the 7-11 convenience store chain in which it <a href=\"https://seekingalpha.com/news/3255827-seven-and-buy-sunoco-assets-3_3b\" target=\"_blank\">agreed to sell</a> 1,110 of its retail stores; prior to the deal, SUN was not only \"significantly\" overlevered but unable to cover its distributions and \"headed for capitulation,\" Khan writes.</li>     <li>But Khan says that while the asset sale is a \"game changing\" move, it does not fully erase the case against owning the stock, as SUN did not provide answers to key questions around the deal, including tax implications and plans to address an apparent hole in coverage.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259495\" data-linked=\"Sunoco upgraded at Citi on &quot;best deal team in the game&quot;\" data-tweet=\"$SUN - Sunoco upgraded at Citi on &quot;best deal team in the game&quot; https://seekingalpha.com/news/3259495-sunoco-upgraded-citi-on-best-deal-team-in-game?source=tweet\" data-url=\"https://seekingalpha.com/news/3259495-sunoco-upgraded-citi-on-best-deal-team-in-game\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259491\" data-ts=\"1493146111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAT\" target=\"_blank\">CAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259491-caterpillarplus-7_5-after-strong-quarter-deere-surges-to-all-time-highs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caterpillar +7.5% after strong quarter; Deere surges to all-time highs</a></h4><ul>     <li>Caterpillar (<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='green'>+7.5%</font>) rallies to its highest levels in more than two years after <a href=\"https://seekingalpha.com/news/3259271-caterpillar-beats-0_66-beats-revenue\" target=\"_blank\">Q1 earnings</a> and revenues blew past estimates and <a href=\"https://seekingalpha.com/news/3259297-caterpillar-leaps-crushing-estimates\" target=\"_blank\">upwardly revising</a> its full-year forecast.</li>     <li>&ldquo;We&rsquo;re starting to feel better about things than maybe even about four months ago,&rdquo; CFO Brad Halverson says, adding that <a href=\"https://www.bloomberg.com/news/articles/2017-04-25/china-helps-make-caterpillar-great-again-as-sales-view-brightens\" target=\"_blank\">China&rsquo;s &ldquo;tremendous&rdquo; surge in demand</a> in the quarter was &ldquo;more than we expected.&rdquo;</li>     <li>&ldquo;Clearly, encouraging signs are emerging that CAT&rsquo;s end markets are finally turning around following a very challenging four-year period,&rdquo; Edward Jones analyst Matt Arnold says.</li>     <li>The improved outlook comes as CAT <a href=\"https://seekingalpha.com/news/3258951-caterpillar-reports-retail-statistics-ending-march\" target=\"_blank\">yesterday</a> reported a measure of worldwide retail sales of its machines had increased for the first time since November 2012.</li>     <li>TD Securities analyst do not necessarily see CAT&rsquo;s strong quarter <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/04/25/caterpillar-fixing-a-hole/\" target=\"_blank\">translating over to other machinery companies</a>, but Deere (<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='green'>+2.7%</font>) is breaking out to all-time highs, and Cummins (<a href='https://seekingalpha.com/symbol/CMI' title='Cummins Inc.'>CMI</a> <font color='green'>+2.2%</font>), Komatsu (<a href='https://seekingalpha.com/symbol/KMTUY' title='Komatsu Ltd. ADR'>OTCPK:KMTUY</a> <font color='green'>+4.8%</font>) and Ritchie Bros. Auctioneers (<a href='https://seekingalpha.com/symbol/RBA' title='Ritchie Bros. Auctioneers Inc.'>RBA</a> <font color='green'>+1.6%</font>) also enjoy strong gains.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259491\" data-linked=\"Caterpillar +7.5% after strong quarter; Deere surges to all-time highs\" data-tweet=\"$CAT $CAT $DE - Caterpillar +7.5% after strong quarter; Deere surges to all-time highs https://seekingalpha.com/news/3259491-caterpillarplus-7_5-after-strong-quarter-deere-surges-to-all-time-highs?source=tweet\" data-url=\"https://seekingalpha.com/news/3259491-caterpillarplus-7_5-after-strong-quarter-deere-surges-to-all-time-highs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259487\" data-ts=\"1493144477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSAT\" target=\"_blank\">GSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259487-globalstar-straight-path-climbing-amid-spectrum-battle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globalstar, Straight Path climbing amid spectrum battle</a></h4><ul>   <li>Globalstar (NYSEMKT:<a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a>) -- a fellow small wireless spectrum holder along with Straight Path Communications -- is <font color='green'>up 6.4%</font> and hitting points last seen last June in the wake of the latter's news that a large multinational telecom is <a href=\"https://seekingalpha.com/news/3259375-straight-path-plus-8_2-percent-new-bidder-tops-and-t-buyout-deal\" target=\"_blank\">topping AT&amp;T's buyout bid</a>.</li>    <li>That's surely Verizon, though neither company is commenting. Straight Path has been gaining throughout the day, now <font color='green'>up 15.3%</font> and well over the bid price received (current quote $127.88 vs. new buyout bid for $104.64), in anticipation of an all-out bidding war for the company's millimeter wave spectrum, which will give the winner an inside track to 5G development.</li>    <li>\"Clearly ultra-high band spectrum is a critical part of both AT&amp;T and Verizon's 5G plans,\" writes Wells Fargo's Jennifer Fritzsche. \"We believe it fair to assume (Verizon) would like to add to this part of its spectrum portfolio with the Straight Path assets.\"</li>    <li>Dish Network (NASDAQ:<a href='https://seekingalpha.com/symbol/DISH' title='DISH Network Corporation'>DISH</a>), another company with large overall spectrum holdings, is <font color='green'>up 3%</font>. Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) is <font color='green'>up 2.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259487\" data-linked=\"Globalstar, Straight Path climbing amid spectrum battle\" data-tweet=\"$GSAT $GSAT $DISH - Globalstar, Straight Path climbing amid spectrum battle https://seekingalpha.com/news/3259487-globalstar-straight-path-climbing-amid-spectrum-battle?source=tweet\" data-url=\"https://seekingalpha.com/news/3259487-globalstar-straight-path-climbing-amid-spectrum-battle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>246&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259486\" data-ts=\"1493144409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259486-teva-finance-chief-to-depart-for-likely-chairmanship-consumer-credit-firm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva finance chief to depart for likely chairmanship at consumer credit firm</a></h4><ul><li>Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-2.6%</font>) SVP and CFO Eyal Desheh plans to <a href=\"http://www.globes.co.il/en/article-teva-cfo-eyal-desheh-to-step-down-1001186241\" target=\"_blank\">step down</a> ahead of his likely appointment as Chairman of Isracard, an Israeli credit card company. Mr. Desheh was Deputy CFO from 1989 - 1996 and was appointed CFO in 2008.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259486\" data-linked=\"Teva finance chief to depart for likely chairmanship at consumer credit firm\" data-tweet=\"$TEVA - Teva finance chief to depart for likely chairmanship at consumer credit firm https://seekingalpha.com/news/3259486-teva-finance-chief-to-depart-for-likely-chairmanship-consumer-credit-firm?source=tweet\" data-url=\"https://seekingalpha.com/news/3259486-teva-finance-chief-to-depart-for-likely-chairmanship-consumer-credit-firm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259485\" data-ts=\"1493144361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEX\" target=\"_blank\">TEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259485-terexplus-8-j-p-morgan-upgrades-citing-company-s-2020-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Terex +8% as J.P. Morgan upgrades, citing company\u2019s 2020 targets</a></h4><ul>     <li>Terex (<a href='https://seekingalpha.com/symbol/TEX' title='Terex Corporation'>TEX</a> <font color='green'>+7.9%</font>) soars to 52-week highs after J.P. Morgan <a href=\"https://www.streetinsider.com/Analyst+PT+Change/UPDATE%3A+JPMorgan+Upgrades+Terex+%28TEX%29+to+Overweight/12808059.html\" target=\"_blank\">upgrades</a> shares to Overweight from Neutral with a $47 price target, hiked from $30, saying TEX could deliver 2020 EPS of ~$4.15 using its framework for 2020 transformation objectives.</li><li>JPM&nbsp;Ann Duignan says TEX&rsquo;s framework has similarities with Illinois Tool Works&rsquo; (<a href='https://seekingalpha.com/symbol/ITW' title='Illinois Tool Works Inc.'>ITW</a> <font color='red'>-0.4%</font>) strategy  that was rolled out in 2012, noting that ITW has exceeded its objectives  and the stock has delivered 140% cumulative total shareholder returns  since 2012.</li><li>Thanks to the upgrade, TEX shares have touched their highest level since September 2014 on volume 3.7x of the 20-day average.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259485\" data-linked=\"Terex +8% as J.P. Morgan upgrades, citing company\u2019s 2020 targets\" data-tweet=\"$TEX $TEX $ITW - Terex +8% as J.P. Morgan upgrades, citing company\u2019s 2020 targets https://seekingalpha.com/news/3259485-terexplus-8-j-p-morgan-upgrades-citing-company-s-2020-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3259485-terexplus-8-j-p-morgan-upgrades-citing-company-s-2020-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259482\" data-ts=\"1493143850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SODA\" target=\"_blank\">SODA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259482-susquehanna-boosts-price-target-on-sodastream\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna boosts its price target on SodaStream</a></h4><ul>     <li>Susquehanna analyst Pablo Zuanic adjusts his FY17 EPS&nbsp;estimate on SodaStream International (<a href='https://seekingalpha.com/symbol/SODA' title='SodaStream International'>SODA</a> <font color='green'>+0.9%</font>) to $2.57 vs. $2.26 prior due to a higher assumption on the company's U.S. penetration rate.</li>     <li>\"To value SODA, we now take a 25% discount as opposed to -35% before given what we think is a more focused business strategy. Our approach yields a price target of $60 by December &rsquo;17 vs. $58 before,\" writes Zuanic.</li><li>SodaStream hit a 52-week high of $55.94 earlier today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259482\" data-linked=\"Susquehanna boosts its price target on SodaStream\" data-tweet=\"$SODA - Susquehanna boosts its price target on SodaStream https://seekingalpha.com/news/3259482-susquehanna-boosts-price-target-on-sodastream?source=tweet\" data-url=\"https://seekingalpha.com/news/3259482-susquehanna-boosts-price-target-on-sodastream\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259474\" data-ts=\"1493142381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAS\" target=\"_blank\">HAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259474-stifel-nicolaus-weighs-in-on-hasbro\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel Nicolaus weighs in on Hasbro</a></h4><ul>     <li>Stifel Nicolaus <a href=\"https://www.streetinsider.com/Analyst+Comments/Hasbro+%28HAS%29%3A+Not+As+Good+As+The+Headline+-+Stifel/12808679.html\" target=\"_blank\">maintains</a> a Hold rating on Hasbro (<a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a> <font color='red'>-0.6%</font>) on a lukewarm assessment of the company's Q1 earnings report.</li><li>\"We view this as a low-quality earnings beat, but considering the company's favorable POS trends/retail inventory position/strong entertainment line-up, we've made modest upward revisions to estimates,\" reads the firm's note.</li><li>Stifel moves its price target to just $100 on its view that valuation is rich at 20.6X 2017 EPS. Hasbro traded as high as $104.14 yesterday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258872-hasbro-positive-post-q1-results\" target=\"_blank\">Hasbro positive post Q1 results</a> (April 24)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258970-hasbro-passes-mattel-sales\" target=\"_blank\">Hasbro passes Mattel in sales</a> (April 24)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259474\" data-linked=\"Stifel Nicolaus weighs in on Hasbro\" data-tweet=\"$HAS - Stifel Nicolaus weighs in on Hasbro https://seekingalpha.com/news/3259474-stifel-nicolaus-weighs-in-on-hasbro?source=tweet\" data-url=\"https://seekingalpha.com/news/3259474-stifel-nicolaus-weighs-in-on-hasbro\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259459\" data-ts=\"1493139641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259459-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+48%</font>. <a href='https://seekingalpha.com/symbol/ATLC' title='Atlanticus Holdings Corp.'>ATLC</a> <font color='green'>+18%</font>.<a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LKFN' title='Lakeland Financial Corporation'>LKFN</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/EQS' title='Equus Total Return'>EQS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='red'>-15%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259459\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$CCCR-OLD $ATLC $PN - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3259459-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3259459-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259458\" data-ts=\"1493139069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AST\" target=\"_blank\">AST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259458-asterias-bios-study-of-ast-opc1-in-acute-spinal-cord-injury-to-continue-shares-ahead-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asterias Bio&#39;s study of AST-OPC1 in acute spinal cord injury to continue; shares ahead 10%</a></h4><ul><li>Asterias Biotherapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/AST' title='Asterias Biotherapeutics, Inc.'>AST</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;on double normal volume in response to its <a href=\"https://seekingalpha.com/pr/16808636-asterias-biotherapeutics-announces-data-monitoring-committee-unanimously-recommends\" target=\"_blank\">announcement </a>that, based on the recommendation from the Data Monitoring Committee, its Phase 1/2a clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02302157?term=scistar&amp;rank=1\" target=\"_blank\">SCiStar</a>, assessing AST-OPC1 in acute spinal injury will continue as planned without modification.</li><li>According to ClinicalTrials.gov, the estimated study completion date is September 2018. The enrollment target is 35 subjects.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259458\" data-linked=\"Asterias Bio&#39;s study of AST-OPC1 in acute spinal cord injury to continue; shares ahead 10%\" data-tweet=\"$AST - Asterias Bio&#39;s study of AST-OPC1 in acute spinal cord injury to continue; shares ahead 10% https://seekingalpha.com/news/3259458-asterias-bios-study-of-ast-opc1-in-acute-spinal-cord-injury-to-continue-shares-ahead-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3259458-asterias-bios-study-of-ast-opc1-in-acute-spinal-cord-injury-to-continue-shares-ahead-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259457\" data-ts=\"1493138928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259457-teck-resourcesminus-5-zinc-production-drop-drags-down-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck Resources -5% as zinc production drop drags down earnings</a></h4><ul>     <li>Teck Resources (NYSE:<a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a>) sinks more than 5% after reporting disappointing <a href=\"https://seekingalpha.com/news/3259181-teck-resources-misses-c-0_13\" target=\"_blank\">Q1 earnings</a> and revenues on <a href=\"http://www.reuters.com/article/us-teck-res-results-idUSKBN17R0QW\" target=\"_blank\">weakness at its zinc unit</a>.</li><li>The unit reported Q1 gross profit of $164M on  higher operating costs and a 23% drop in production at Teck's Red Dog  mine due to lower grades, and Teck cut its 2017 total zinc production guidance to 590K-615K metric tons from 660K-680K metric tons previously, due to weather and electrical equipment failures at Red Dog.</li><li>Teck adds that the Q2 benchmark price for steelmaking coal has yet to be agreed upon due to the impact of Cyclone  Debbie on Australian supply; it reaffirms a Q2 sales forecast of at least 6.8M metric tons of steelmaking coal.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259457\" data-linked=\"Teck Resources -5% as zinc production drop drags down earnings\" data-tweet=\"$TECK - Teck Resources -5% as zinc production drop drags down earnings https://seekingalpha.com/news/3259457-teck-resourcesminus-5-zinc-production-drop-drags-down-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3259457-teck-resourcesminus-5-zinc-production-drop-drags-down-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259455\" data-ts=\"1493138726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259455-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+46%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/ATLC' title='Atlanticus Holdings Corp.'>ATLC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/NORD' title='Nord Anglia Education Inc.'>NORD</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/HSTM' title='HealthStream, Inc.'>HSTM</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CALI' title='China Auto Logistics Inc.'>OTC:CALI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='red'>-31%</font>. GFA <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/FNBC' title='First NBC Bank Holding Company'>OTC:FNBC</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/HSII' title='Heidrick & Struggles International, Inc.'>HSII</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals'>RTTR</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/R' title='Ryder System, Inc.'>R</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/PZRX' title='PhaseRx'>PZRX</a>&nbsp;<font color='red'>-12%.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3259455\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CCCR-OLD $LXU $ATLC - Midday Gainers / Losers https://seekingalpha.com/news/3259455-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3259455-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259450\" data-ts=\"1493138058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTK\" target=\"_blank\">PRTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259450-parateks-iv-omadacycline-effective-in-penetrating-lung-tissue-and-epithelial-lining-fluid-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Paratek&#39;s IV omadacycline effective in penetrating lung tissue and epithelial lining fluid in early-stage study</a></h4><ul><li>Data from a Phase 1 study of Paratek Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a>) broad spectrum antibiotic omadacycline showed intravenous administration produced steady-state concentrations in the plasma and key structures that were 3x higher than tigecycline in healthy subjects. On the safety front, there were no serious adverse events following IV dosing and there was a lower incidence of gastrointestinal adverse events compared to tigecycline.</li><li>The results were presented at the European Congress of Clinical Microbiology and Infectious Diseases ((ECCMID)) in Vienna.</li><li>COO and CMO Evan Loh, M.D., says, &ldquo;Throughout our clinical development program, we have worked to generate a thorough understanding of all aspects of omadacycline and share that information with the scientific and clinical community. These data add to the growing body of evidence to support omadacycline as an effective agent in the treatment of serious acquired bacterial infections, particularly where resistance is of concern to prescribing physicians.&rdquo;</li><li>The company plans to file its U.S. marketing application as early as Q1 2018 followed by its filing in Europe.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;on lower-than-normal volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259450\" data-linked=\"Paratek&#39;s IV omadacycline effective in penetrating lung tissue and epithelial lining fluid in early-stage study\" data-tweet=\"$PRTK - Paratek&#39;s IV omadacycline effective in penetrating lung tissue and epithelial lining fluid in early-stage study https://seekingalpha.com/news/3259450-parateks-iv-omadacycline-effective-in-penetrating-lung-tissue-and-epithelial-lining-fluid-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3259450-parateks-iv-omadacycline-effective-in-penetrating-lung-tissue-and-epithelial-lining-fluid-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259451\" data-ts=\"1493137882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259451-gold-miners-extend-sharp-losses-risky-assets-rule-barrick-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold, miners extend sharp losses as risky assets rule, Barrick disappoints</a></h4><ul>     <li><a href=\"http://www.marketwatch.com/story/gold-adds-to-declines-as-risky-assets-draw-demand-2017-04-25\" target=\"_blank\">Gold futures and gold miners trade broadly lower</a>, extending yesterday&rsquo;s big drop amid the rise in risk-on sentiment that followed France&rsquo;s presidential election results.</li>     <li>&ldquo;Traders&rsquo; expectation that Le Pen will not become the next French President has resulted in a technical correction for gold and silver,&rdquo; says Chintan Karnani, chief market analyst at Insignia Consultants, and if the technical correction continues until Friday, it would &ldquo;mark the beginning of a short-term bearish phase.\"</li>     <li>Results are <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/04/25/barrick-newmont-all-that-glitters-is-not-gold/?mod=BOL_hp_blog_stw\" target=\"_blank\">exacerbated</a> by a relatively rare <a href=\"https://seekingalpha.com/news/3259416-barrick-gold-minus-10-percent-cuts-production-outlook-veladero-spill\" target=\"_blank\">quarterly earnings miss</a> from Barrick Gold, which had beaten in five of the previous six quarters, hurt by lower production and higher costs than expected; Newmont Mining is down 5% even after a <a href=\"https://seekingalpha.com/news/3259074-newmont-mining-beats-0_02-misses-revenue\" target=\"_blank\">Q1 earnings beat</a> with a 2017 outlook that remained mostly unchanged.</li><li>ABX <font color='red'>-10.4%</font>, <a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='red'>-4.7%</font>, <a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='red'>-4.7%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color='red'>-6.4%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='red'>-5.4%</font>, <a href='https://seekingalpha.com/symbol/EGO' title='Eldorado Gold Corporation'>EGO</a> <font color='red'>-5.3%</font>, <a href='https://seekingalpha.com/symbol/FNV' title='Franco-Nevada Corporation'>FNV</a> <font color='red'>-3.2%</font>, <a href='https://seekingalpha.com/symbol/NG' title='NovaGold Resources, Inc'>NG</a> <font color='red'>-8%</font>, <a href='https://seekingalpha.com/symbol/GORO' title='Gold Resource Corporation'>GORO</a> <font color='red'>-7.8%</font>, <a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='red'>-7.7%</font>, <a href='https://seekingalpha.com/symbol/AUY' title='Yamana Gold Inc.'>AUY</a> <font color='red'>-6.8%</font>, <a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color='red'>-2.5%</font>, <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='red'>-2.6%</font>, SLW <font color='red'>-5.5%</font>, <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines'>FSM</a> <font color='red'>-8.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/ZSL' title='ProShares UltraShort Silver ETF'>ZSL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/JDST' title='Direxion Daily Junior Gold Miners Index Bear 3x Shares ETF'>JDST</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/DSLV' title='VelocityShares 3x Inverse Silver ETN'>DSLV</a>, <a href='https://seekingalpha.com/symbol/SLVP' title='iShares MSCI Global Silver Miners ETF'>SLVP</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/DBS' title='Invesco DB Silver ETF'>DBS</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/PSAU' title='Invesco Global Gold and Precious Metals Portfolio ETF'>PSAU</a>, <a href='https://seekingalpha.com/symbol/SGDJ' title='Sprott Junior Gold Miners ETF'>SGDJ</a>, <a href='https://seekingalpha.com/symbol/TGLDX' title='Tocqueville Gold Fund No Load'>TGLDX</a>, <a href='https://seekingalpha.com/symbol/USV' title='UBS ETRACS CMCI Silver Total Return ETN'>USV</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/GDJJ' title='ProShares Ultra Junior Miners ETF'>GDJJ</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259451\" data-linked=\"Gold, miners extend sharp losses as risky assets rule, Barrick disappoints\" data-tweet=\"$GOLD $GOLD $NEM - Gold, miners extend sharp losses as risky assets rule, Barrick disappoints https://seekingalpha.com/news/3259451-gold-miners-extend-sharp-losses-risky-assets-rule-barrick-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3259451-gold-miners-extend-sharp-losses-risky-assets-rule-barrick-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>89&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259444\" data-ts=\"1493137190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBC\" target=\"_blank\">FBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259444-flagstar-bancorpplus-2_15-after-q1-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flagstar Bancorp +2.15% after Q1 beat</a></h4><ul><li>Q1 net income of $27M or $0.46 per share vs. $39M and $0.54 one year ago, but topping estimates by $0.08.</li><li>ROA of 0.8% down 40 basis points Y/Y; ROE of 7.9% down 430 bps; efficiency ratio of 76.8% deteriorates 230 bps.</li><li>Net interest income of $83M vs. $79M a year ago; NIM of 2.67% flat from Q4, up one basis point Y/Y. Average loans held for sale of $3.3B up 13% Y/Y; average loans held for investment of $5.6B down 1%. Average deposits of $8.8B up 9%.</li><li>Provisions of $3M vs. a benefit of $13M a year ago.</li><li>Noninterest income of $100M vs. $105M a year ago; noninterest expense of $140M vs. $137M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259221-flagstar-beats-0_08-misses-net-interest-income\" target=\"_blank\">Flagstar beats by $0.08, misses on net interest income</a> (April 25)</li><li><a href='https://seekingalpha.com/symbol/FBC' title='Flagstar Bancorp, Inc.'>FBC</a>&nbsp;<font color='green'>+2.15%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3259444\" data-linked=\"Flagstar Bancorp +2.15% after Q1 beat\" data-tweet=\"$FBC - Flagstar Bancorp +2.15% after Q1 beat https://seekingalpha.com/news/3259444-flagstar-bancorpplus-2_15-after-q1-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3259444-flagstar-bancorpplus-2_15-after-q1-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259442\" data-ts=\"1493136437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FITB\" target=\"_blank\">FITB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259442-fifth-third-drops-1-after-q1-results-total-loans-down-1-from-last-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fifth Third drops 1% after Q1 results; total loans down 1% from last year</a></h4><ul><li>Q1 net income of $290M or $0.38 per share down from &nbsp;$311M and $0.40 a year ago, but topped estimates by a penny. Share float fell 3% to 750M.</li><li>Total loans and leases of $92.8B down 1% from Q4, down 1% Y/Y.</li><li>ROA of 0.88% down 5 basis points Y/Y; ROTCE of 9.3% down 60 bps. CET1 capital (fully phased) of 10.66% up 94 bps.</li><li>Net interest margin of 3.02% up 16 bps for the quarter, up 11 bps Y/Y. Efficiency ratio deteriorates to 67.4% from 63.8% a year ago.</li><li>Net charge-offs of $89M, up $16M from Q4, down $7M from a year ago; NCO ratio of 0.40% down 2 basis points Y/Y; portfolio NPA ratio of 0.79% down 9 bps.</li><li>Tangible book value per share of $16.89 up 2% during quarter, up 3% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259227-fifth-third-bancorp-beats-0_01-misses-revenue\" target=\"_blank\">Fifth Third Bancorp beats by $0.01, misses on revenue</a> (April 25)</li><li><a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a>&nbsp;<font color='red'>-0.95%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3259442\" data-linked=\"Fifth Third drops 1% after Q1 results; total loans down 1% from last year\" data-tweet=\"$FITB - Fifth Third drops 1% after Q1 results; total loans down 1% from last year https://seekingalpha.com/news/3259442-fifth-third-drops-1-after-q1-results-total-loans-down-1-from-last-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3259442-fifth-third-drops-1-after-q1-results-total-loans-down-1-from-last-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259440\" data-ts=\"1493136067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259440-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/TUP' title='Tupperware Brands Corporation'>TUP</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/APFH' title='AdvancePierre Foods Holdings'>APFH</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SCL' title='Stepan Co.'>SCL</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259440\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$WNC $TUP $APFH - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3259440-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3259440-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259438\" data-ts=\"1493135978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVS\" target=\"_blank\">NVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259438-money-flow-surges-in-biotechs-novartis-aims-for-early-stage-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Money flow surges in biotechs, Novartis aims for more early-stage deals</a></h4><ul><li>Biotechs are among the leaders in a broad market rally today. Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) (<font color='green'>+2.4%</font>) added punch to the party with its earnings call <a href=\"https://www.briefing.com/investor/analysis/story-stocks/biotech-stocks-surge-after-novartis-signals-more-dealmaking-for-early-stage-assets-%28xbi%29.htm\" target=\"_blank\">comments </a>about seeking new early-stage acquisitions and in-licensing deals to beef up its pipeline.</li><li>Representative tickers: (NASDAQ:<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a>)(<font color='green'>+1.5%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a>)(<font color='green'>+3.1%</font>) (NYSEARCA:<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a>)(<font color='green'>+2.3%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a>)(<font color='green'>+3.2%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) (<font color='green'>+0.4%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) (<font color='green'>+1.1%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/AERI' title='Aerie Pharmaceuticals, Inc.'>AERI</a>) (<font color='green'>+2.9%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a>) (+5.4%)(NASDAQ:<a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals'>PTLA</a>) (<font color='green'>+2.9%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>) (<font color='green'>+1.0%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) (<font color='green'>+4.4%</font>) (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) (<font color='green'>+1.0%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3259438\" data-linked=\"Money flow surges in biotechs, Novartis aims for more early-stage deals\" data-tweet=\"$NVS $NVS $IBB - Money flow surges in biotechs, Novartis aims for more early-stage deals https://seekingalpha.com/news/3259438-money-flow-surges-in-biotechs-novartis-aims-for-early-stage-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/3259438-money-flow-surges-in-biotechs-novartis-aims-for-early-stage-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259441\" data-ts=\"1493135927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259441-valero-ceo-sees-q2-biofuel-costs-significant-headwind\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valero CEO sees Q2 biofuel costs as a &quot;significant headwind&quot;</a></h4><ul>     <li>Valero Energy (NYSE:<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a>) sinks ~2.5% as Chairman and CEO Joe Gorder says he expects costs for renewable fuel credits to <a href=\"http://www.reuters.com/article/refineries-valero-rins-idUSL1N1HX0S1\" target=\"_blank\">drag on the company's returns in Q2</a>.</li>     <li>\"While RIN prices have declined  relative to 2016, there is still a significant headwind for the  quarter... At this level, RINs expense remain an issue for us, so we continue to work with regulators,\" Gorder says in this morning's earnings conference call.</li>     <li>Gary Simmons, VLO senior VP of international operations and system optimization, said during the call that VLO is not ready to revise its forecast for RINs for 2017; VLO has said it expects to spend an amount similar to the $749M spent in 2016 to meet U.S. renewable fuel requirements.</li><li>VLO's <a href=\"https://seekingalpha.com/news/3259228-valero-energy-beats-0_05-beats-revenue\" target=\"_blank\">Q1 earnings</a> came in ahead of estimates; Q1 biofuel blending costs were $146M,  which was $15M lower than in the year-ago quarter.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259441\" data-linked=\"Valero CEO sees Q2 biofuel costs as a &quot;significant headwind&quot;\" data-tweet=\"$VLO - Valero CEO sees Q2 biofuel costs as a &quot;significant headwind&quot; https://seekingalpha.com/news/3259441-valero-ceo-sees-q2-biofuel-costs-significant-headwind?source=tweet\" data-url=\"https://seekingalpha.com/news/3259441-valero-ceo-sees-q2-biofuel-costs-significant-headwind\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259433\" data-ts=\"1493134798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLW\" target=\"_blank\">GLW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259433-corningplus-3_8-after-swinging-to-profit-on-strong-sales-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corning +3.8% after swinging to profit on strong sales growth</a></h4><ul>   <li>Corning (NYSE:<a href='https://seekingalpha.com/symbol/GLW' title='Corning Inc.'>GLW</a>) is <font color='green'>up 3.8%</font> after logging a <a href=\"https://seekingalpha.com/news/3259258-corning-beats-0_04-beats-revenue\" target=\"_blank\">Q1 earnings report</a> where it swung to a profit in GAAP terms and core EPS rose 39%.</li>    <li>Financial measures grew across the board, and the company pointed to continued rapid adoption of Gorilla Glass 5 as it pursues doubling sales in mobile consumer electronics.</li>    <li>The company works to stabilize returns in its Display Technologies unit; it says Q1 LCD glass price declines were the most moderate in the past six years, and full-year LCD glass prices are expected to decline by about 10% or even less.</li>    <li>GAAP net sales by segment: Display Technologies, $736M (up 4%); Optical Communications, $818M (up 34%); Environmental Technologies, $275M (up 4%); Specialty Materials, $300M (up 32%); Life Sciences, $210M (up 3%).</li>    <li>The company says it's off to a strong start and expects \"year-over-year sales and earnings growth in the second quarter.&rdquo;</li>    <li><a href=\"https://www.sec.gov/Archives/edgar/data/24741/000002474117000022/glw-20170425xex99.htm\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3259433\" data-linked=\"Corning +3.8% after swinging to profit on strong sales growth\" data-tweet=\"$GLW - Corning +3.8% after swinging to profit on strong sales growth https://seekingalpha.com/news/3259433-corningplus-3_8-after-swinging-to-profit-on-strong-sales-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3259433-corningplus-3_8-after-swinging-to-profit-on-strong-sales-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259431\" data-ts=\"1493134472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSII\" target=\"_blank\">HSII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259431-heidrick-strugglesminus-16-after-weak-sales-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heidrick &amp; Struggles -16% after weak sales view</a></h4><ul> <li>Heidrick &amp; Struggles International (NASDAQ:<a href='https://seekingalpha.com/symbol/HSII' title='Heidrick & Struggles International, Inc.'>HSII</a>) <font color='red'>falls 15.70%</font> after setting Q2 guidance at $153M to $163M vs. $160.8M consensus.</li> <li>Revenue from the culture shaping segment fell 31% Y/Y during the <a href=\"https://seekingalpha.com/pr/16808074-heidrick-and-struggles-reports-first-quarter-2017-financial-results\" target=\"_blank\">Q1</a>, although management says it's confident on growth over the longer term.</li> <li>Heidrick &amp; Struggles trades at its lowest level since late February. Shares are now down 6.42% YTD.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259051-heidrick-and-struggles-misses-0_02-misses-revenue\" target=\"_blank\">Heidrick &amp; Struggles misses by $0.02, misses on revenue</a> (April 24)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3259431\" data-linked=\"Heidrick &amp; Struggles -16% after weak sales view\" data-tweet=\"$HSII - Heidrick &amp; Struggles -16% after weak sales view https://seekingalpha.com/news/3259431-heidrick-strugglesminus-16-after-weak-sales-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3259431-heidrick-strugglesminus-16-after-weak-sales-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259428\" data-ts=\"1493133815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSTM\" target=\"_blank\">HSTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259428-healthstream-q1-top-line-up-11-cash-flow-up-190-shares-ahead-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HealthStream Q1 top line up 11%; cash flow up 190%; shares ahead 17%</a></h4><ul><li>HealthStream (NASDAQ:<a href='https://seekingalpha.com/symbol/HSTM' title='HealthStream, Inc.'>HSTM</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/16808190-healthstream-announces-first-quarter-2017-results\" target=\"_blank\">Q1 results</a> ($M): Revenues: 59.9 (+10.7%).</li><li>Net Income: 1.3 (-14.4%); Non-GAAP Net Income: 1.8 (-11.3%); EPS: 0.04 (-20.0%); cash flow ops: 16.5 (+189.5%).</li><li><strong>2017 Guidance</strong>: Revenue growth: 10 - 14%; operating income growth: 50 - 65%; capex: $15M - 17M.</li><li>EPS was in-line with consensus while revenues beat by ~$0.7M.</li><li>Revenue for Workforce Solutions was up 2.4M (+5.8%) but offset by a $3.4M decline in ICD-10 readiness.</li><li>Shares are up&nbsp;<font color='green'>17%</font>&nbsp;on triple normal volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259428\" data-linked=\"HealthStream Q1 top line up 11%; cash flow up 190%; shares ahead 17%\" data-tweet=\"$HSTM - HealthStream Q1 top line up 11%; cash flow up 190%; shares ahead 17% https://seekingalpha.com/news/3259428-healthstream-q1-top-line-up-11-cash-flow-up-190-shares-ahead-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3259428-healthstream-q1-top-line-up-11-cash-flow-up-190-shares-ahead-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259426\" data-ts=\"1493133080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WNC\" target=\"_blank\">WNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259426-wabash-national-rips-12-gain-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wabash National rips 12% gain after earnings</a></h4><ul> <li>Wabash National Corporation (NYSE:<a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a>) spikes after a Q1 profit beat.</li> <li>Gross margin arrived up 140 bps Y/Y at 17.8% of sales. Operating EBITDA margin was up 180 bps to 13.4$ of sales during the quarter.</li> <li>Wabash CEO Dick Giromini's industry look: \"Backlog grew once again, coming in at a seasonally and historically strong $863 million, continuing to support our long-standing belief that trailer fleet age, regulatory compliance requirements, and customer profitability provide strong support for a continued favorable demand environment.\"</li> <li>Shares of Wabash are <font color='green'>up 11.89%</font> to $22.78 and traded at a 52-week high of $22.82 earlier.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259094-wabash-national-beats-0_04-misses-revenue\" target=\"_blank\">Wabash National beats by $0.04, misses on revenue</a> (April 24)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259426\" data-linked=\"Wabash National rips 12% gain after earnings\" data-tweet=\"$WNC - Wabash National rips 12% gain after earnings https://seekingalpha.com/news/3259426-wabash-national-rips-12-gain-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3259426-wabash-national-rips-12-gain-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259425\" data-ts=\"1493132643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVU\" target=\"_blank\">SVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259425-supervaluplus-10-off-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Supervalu +10% off profit beat</a></h4><ul> <li>Supervalu (NYSE:<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a>) spikes after the grocery chain showed margin improvement in FQ4. Gross margin came in at 15.0% of sales vs. +14.4% consensus.</li> <li>\"We finished fiscal 2017 with momentum in our wholesale business and an improved balance sheet resulting from the sale of Save-A-Lot,\" notes CEO Mark Gross.</li> <li>Shares of Supervalu are <font color='green'>up 9.84%</font> after the profit beat to trade at their highest level since January.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3259214-supervalu-beats-0_04-beats-revenue\" target=\"_blank\">SUPERVALU beats by $0.04, beats on revenue</a> (April 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259224-supervalu-positive-post-q1-results\" target=\"_blank\">Supervalu positive post Q1 results</a> (April 25)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3259425\" data-linked=\"Supervalu +10% off profit beat\" data-tweet=\"$SVU - Supervalu +10% off profit beat https://seekingalpha.com/news/3259425-supervaluplus-10-off-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3259425-supervaluplus-10-off-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259424\" data-ts=\"1493132620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259424-ionisplus-4_25-after-strong-spinraza-sales-from-biogen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ionis +4.25% after strong Spinraza sales from Biogen</a></h4><ul><li>Ionis (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a>&nbsp;<font color='green'>+4.25%</font>) partner <a href=\"https://seekingalpha.com/news/3259242-biogen-beats-0_22-beats-revenue\" target=\"_blank\">Biogen reported Q1 </a>Spinraza sales of $47M vs. estimates for just $15M.</li><li>The drug has been approved for individual use by 100 commercial plans and 65 Medicaid plans; 88 sites over 36 states have administered; 203 sites have submitted start forms.</li><li>Source: <a href=\"https://seekingalpha.com/article/4064873-biogen-inc-2017-q1-results-earnings-call-slides\" target=\"_blank\">Earnings call slides</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259424\" data-linked=\"Ionis +4.25% after strong Spinraza sales from Biogen\" data-tweet=\"$IONS - Ionis +4.25% after strong Spinraza sales from Biogen https://seekingalpha.com/news/3259424-ionisplus-4_25-after-strong-spinraza-sales-from-biogen?source=tweet\" data-url=\"https://seekingalpha.com/news/3259424-ionisplus-4_25-after-strong-spinraza-sales-from-biogen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259409\" data-ts=\"1493132507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259409-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme'>EPZM</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/AMRI' title='Albany Molecular Research, Inc.'>AMRI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/KDMN' title='Kadmon Holdings'>KDMN</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AST' title='Asterias Biotherapeutics, Inc.'>AST</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/RTTR' title='Ritter Pharmaceuticals'>RTTR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AZRX' title='AzurRX Biopharma'>AZRX</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259409\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$EPZM $CTIC $AMRI - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3259409-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3259409-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259420\" data-ts=\"1493131942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBLU\" target=\"_blank\">JBLU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259420-guidance-helps-lift-jetblue-and-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidance helps lift JetBlue and peers</a></h4><ul>     <li>JetBlue (NASDAQ:<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a>) is higher after knocking out a <a href=\"https://seekingalpha.com/pr/16808715-jetblue-announces-first-quarter-2017-results\" target=\"_blank\">Q1</a> profit beat.</li>     <li>Key metrics for Q1: Revenue passenger miles +3.9%, capacity +4.2%, load factor -30 bps to 83.9%, passenger revenue per available seat mile -5.8%, yield per passenger mile -5.5%, operating expenses per available seat mile +10% (+3.3% ex-fuel), realized fuel price +44% Y/Y to $1.69.</li>     <li>The airline sees Q2 capacity growth of 4% to 6% and a Q2 passenger revenue per available seat mile increase of 3% to 6%.</li>     <li>The better-than-anticipated PRASM guidance from JetBlue appears to be giving a little lift to SkyWest (NASDAQ:<a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a>), Southwest Airlines (NYSE:<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a>) and Allegiant Travel (NASDAQ:<a href='https://seekingalpha.com/symbol/ALGT' title='Allegiant Travel Company'>ALGT</a>) in early trading.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3259267-jetblue-airways-beats-0_02-misses-revenue\" target=\"_blank\">JetBlue Airways beats by $0.02, misses on revenue</a> (April 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259420\" data-linked=\"Guidance helps lift JetBlue and peers\" data-tweet=\"$JBLU $JBLU $SKYW - Guidance helps lift JetBlue and peers https://seekingalpha.com/news/3259420-guidance-helps-lift-jetblue-and-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3259420-guidance-helps-lift-jetblue-and-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259415\" data-ts=\"1493131598\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VYGR\" target=\"_blank\">VYGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259415-voyagers-parkinsons-candidate-vy-aadc01-shows-dose-dependent-effect-in-early-stage-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Voyager&#39;s Parkinson&#39;s candidate VY-AADC01 shows dose-dependent effect in early-stage study, investors unimpressed; shares slip 2%</a></h4><ul><li>Thinly traded micro cap Voyager Therapeutics (<a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics'>VYGR</a> <font color='red'>-2%</font>) is on the outside looking in at the market's early session rally. Shares are down on light volume in apparent reaction to its <a href=\"https://seekingalpha.com/pr/16808684-voyager-therapeutics-announces-additional-results-phase-1b-trial-vy-aadc01-advanced-parkinson\" target=\"_blank\">announcement </a>of results from its Phase 1b study of gene therapy VY-AADC01 in advanced Parkinson's disease. The data were presented at the American Association of Neurological Surgeons Meeting in Los Angeles.</li><li>Treatment with VY-AADC01 produced dose-dependent improvements in functional and quality-of-life measures, specifically the Unified Parkinson's Disease Rating Scale &#40;UPDRS&#41; and the 39-item Parkinson's Disease Questionnaire (PDQ-39).</li><li>Results at month 12 for Cohort 1 (n=5) and Cohort 2 (n=3) showed improvements in UPDRS-IV total score of 24% and 36%, respectively. Improvements in PDQ-39 total score were 10% and 75%, respectively.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3229250-voyager-therapeutics-35-percent-hours-positive-results-early-stage-parkinsons-study\" target=\"_blank\">Voyager Therapeutics up 35% after hours on positive results from early-stage Parkinson's study</a> (Dec. 7, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3259415\" data-linked=\"Voyager&#39;s Parkinson&#39;s candidate VY-AADC01 shows dose-dependent effect in early-stage study, investors unimpressed; shares slip 2%\" data-tweet=\"$VYGR - Voyager&#39;s Parkinson&#39;s candidate VY-AADC01 shows dose-dependent effect in early-stage study, investors unimpressed; shares slip 2% https://seekingalpha.com/news/3259415-voyagers-parkinsons-candidate-vy-aadc01-shows-dose-dependent-effect-in-early-stage-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3259415-voyagers-parkinsons-candidate-vy-aadc01-shows-dose-dependent-effect-in-early-stage-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259418\" data-ts=\"1493131399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAKK\" target=\"_blank\">JAKK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259418-on-jakks-pacifics-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on JAKKS Pacific&#39;s Q1</a></h4><ul>     <li>JAKKS Pacific (NASDAQ:<a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a>) reports operating loss in <a href=\"https://seekingalpha.com/pr/16808529-jakks-pacific-reports-first-quarter-2017-financial-results\" target=\"_blank\">Q1</a>, in part due to incremental overhead and startup costs associated with our C&rsquo;est Moi makeup and skincare product line as well as increased testing costs related to the expansion of sales of certain products in International markets,</li>     <li>Gross margin rate fell 70 bps to 31.8%.</li>     <li>SG&amp;A expense rate grew 230 bps to 34.3%.</li>     <li>Inventory -10.6% Q/Q to $67.5M.</li>     <li>For FY2017, the company expects higher net income, EPS and adjusted EBITDA on lower net sales vs. FY2016.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259418\" data-linked=\"More on JAKKS Pacific&#39;s Q1\" data-tweet=\"$JAKK - More on JAKKS Pacific&#39;s Q1 https://seekingalpha.com/news/3259418-on-jakks-pacifics-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3259418-on-jakks-pacifics-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259416\" data-ts=\"1493130922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259416-barrick-goldminus-10-cuts-production-outlook-after-veladero-spill\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barrick Gold -10%, cuts production outlook after Veladero spill</a></h4><ul>     <li>Barrick Gold (ABX <font color='red'>-9.8%</font>) plunges after reporting weaker than expected <a href=\"https://seekingalpha.com/news/3259129-barrick-gold-misses-0_06-misses-revenue\" target=\"_blank\">Q1 earnings</a> and revenues and lowering its 2017 gold production forecast.</li>     <li>ABX <a href=\"http://www.reuters.com/article/us-barrick-gold-results-idUSKBN17Q2A0\" target=\"_blank\">trimmed its 2017 gold production outlook</a> to 5.3M-5.6M oz. from 5.6M-5.9M oz., with two-thirds of the reduction driven by the sale of 50% stake in its Veladero mine in Argentina, which is expected to close at the end of Q2, and the rest due to a guidance cut at Veladero due to the recent spill; guidance for 2017 gold costs, copper production and costs, and capex were left unchanged.</li>     <li>ABX says it now expects full-year production at Veladero of 630K-730K oz. of gold, at all-in sustaining costs of $890-$990/oz., vs. its previous forecast of 770K-830K&nbsp;oz. at all-in sustaining costs of $840-$940/oz.</li>     <li>Q1 gold production totaled 1.31M oz., at a cost  of sales applicable to gold of $833/oz. and all-in sustaining  costs of $772/oz.</li>     <li>Morgan Stanley's Evan Kurtz, who has an Equal Weight rating on the shares and a $15 price target, says ABX's production outlook was \"<a href=\"http://www.barrons.com/articles/barrick-canary-in-the-gold-mine-1493126532\" target=\"_blank\">largely expected, but carries some risk</a>.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3259416\" data-linked=\"Barrick Gold -10%, cuts production outlook after Veladero spill\" data-tweet=\"$GOLD - Barrick Gold -10%, cuts production outlook after Veladero spill https://seekingalpha.com/news/3259416-barrick-goldminus-10-cuts-production-outlook-after-veladero-spill?source=tweet\" data-url=\"https://seekingalpha.com/news/3259416-barrick-goldminus-10-cuts-production-outlook-after-veladero-spill\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259413\" data-ts=\"1493130553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUP\" target=\"_blank\">TUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259413-strong-guidance-sends-tupperware-to-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong guidance sends Tupperware to 52-week high</a></h4><ul> <li>Tupperware Brands (<a href='https://seekingalpha.com/symbol/TUP' title='Tupperware Brands Corporation'>TUP</a> <font color='green'>+11.8%</font>) pops after topping <a href=\"https://seekingalpha.com/pr/16809388-land-buildings-calls-forest-city-realty-trust-form-special-committee-evaluate-strategic\" target=\"_blank\">Q1</a> estimates by a comfortable margin and setting favorable guidance.</li> <li>The company sees Q2 EPS of $1.17 to $1.22 vs. $1.19 consensus and FY17 EPS of $4.67 to $4.77 vs. $4.56 consensus.</li> <li>Strong demand in Brazil, China, Mexico and South Africa is helping turn the tide for Tupperware.</li> <li>The strong read on sales and profit was enough to push Tupperware to a new 52-week high of $73.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259238-tupperware-beats-0_07-beats-revenue\" target=\"_blank\">Tupperware beats by $0.07, beats on revenue</a> (April 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259413\" data-linked=\"Strong guidance sends Tupperware to 52-week high\" data-tweet=\"$TUP - Strong guidance sends Tupperware to 52-week high https://seekingalpha.com/news/3259413-strong-guidance-sends-tupperware-to-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3259413-strong-guidance-sends-tupperware-to-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259398\" data-ts=\"1493128757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCI\" target=\"_blank\">GCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259398-gannettplus-7_9-after-q1-beat-raised-ebitda-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gannett +7.9% after Q1 beat, raised EBITDA guidance</a></h4><ul>   <li>Gannett (NYSE:<a href='https://seekingalpha.com/symbol/GCI' title='Gannett Co., Inc.'>GCI</a>) is <font color='green'>up 7.9%</font> and reaching its highest point since early February after posting <a href=\"https://seekingalpha.com/news/3259246-gannett-beats-0_03-beats-revenue\" target=\"_blank\">Q1 earnings</a> where it beat on top and bottom lines and raised EBITDA guidance for the full year.</li>    <li>Revenues grew more than 17%; excluding unfavorable exchange-rate changes and $1.8M in exited operations, they grew 19.3%. Digital revenues of $234.7M made up 30.3% of operating revenue.</li>    <li>Net cash flow from operations of about $31.1M, vs. a year-ago $17.3M. Cash balance at quarter's end was $89.5M.</li>    <li>Revenue by segment: Publishing, $694.9M (up 5.6%); ReachLocal, $77.6M (new); Corporate and Other, $968,000 (down 30.3%).</li>    <li>It's boosted EBITDA guidance for the full year to $355M-$365M, up $30M at the midpoint. It's reiterated guidance for revenues of $3.15B-$3.22B, and sees capex of $65-$75M (excluding real estate); depreciation/amortization of $150M-$155M; and effective tax rate of 28-32%.</li>    <li><a href=\"http://investors.gannett.com/\" target=\"_blank\">Conference call</a> coming at 10 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16808641-gannett-reports-first-quarter-2017-results-operations\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3259398\" data-linked=\"Gannett +7.9% after Q1 beat, raised EBITDA guidance\" data-tweet=\"$GCI - Gannett +7.9% after Q1 beat, raised EBITDA guidance https://seekingalpha.com/news/3259398-gannettplus-7_9-after-q1-beat-raised-ebitda-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3259398-gannettplus-7_9-after-q1-beat-raised-ebitda-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259397\" data-ts=\"1493128605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TOL\" target=\"_blank\">TOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259397-homebuilders-slump-amid-tariff-and-pultegroup-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Homebuilders slump amid tariff and PulteGroup results</a></h4><ul><li>The S&amp;P 500 is&nbsp;<font color='green'>up 0.5%</font>&nbsp;in early action, but the <a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a> is<font color='red'> lower by 0.5%</font>.</li><li>Down the most is PulteGroup,&nbsp;<font color='red'>off 4.4%</font>&nbsp;after topping Q1 bottom-line estimates, <a href=\"https://seekingalpha.com/news/3259256-margins-slip-pultegroup-shares-minus-3_4-percent-premarket\" target=\"_blank\">but with gross margin</a> off more than expected.</li><li>Also at work is the Trump administration's slapping of a tariff of up to 24% on Canadian softwood imports - the resulting increase in lumber costs would seemingly threaten homebuilders' gross margins even more.</li><li>Toll Brothers (<a href='https://seekingalpha.com/symbol/TOL' title='Toll Brothers Inc.'>TOL</a> <font color='red'>-0.7%</font>), D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a> <font color='red'>-1.1%</font>), Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='red'>-1.1%</font>), KB Home (<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color='red'>-1.4%</font>), NVR (<a href='https://seekingalpha.com/symbol/NVR' title='NVR, Inc.'>NVR</a> <font color='red'>-1.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3259397\" data-linked=\"Homebuilders slump amid tariff and PulteGroup results\" data-tweet=\"$TOL $ITB $TOL - Homebuilders slump amid tariff and PulteGroup results https://seekingalpha.com/news/3259397-homebuilders-slump-amid-tariff-and-pultegroup-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3259397-homebuilders-slump-amid-tariff-and-pultegroup-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259392\" data-ts=\"1493127730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259392-loonie-slides-to-weakest-level-of-year-after-trump-tariff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loonie slides to weakest level of year after Trump tariff</a></h4><ul><li>The Trump administration yesterday began the process of imposing a tariff of up to 24% on Canadian softwood imports into the U.S.</li><li><a href=\"https://twitter.com/realDonaldTrump/status/856847826663460865\" target=\"_blank\">Trump tweets</a>: \"Canada has made business for our dairy farmers in Wisconsin and other border states very difficult. We will not stand for this. Watch!\"</li><li>The loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) is<font color='red'> lower by 0.75%</font>&nbsp;vs, the greenback to $0.7353, its weakest level since late last year. Stocks in Toronto are&nbsp;<font color='green'>higher by 0.45%</font>&nbsp;in early action.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3259392\" data-linked=\"Loonie slides to weakest level of year after Trump tariff\" data-tweet=\"$FXC $EWC $CNDA - Loonie slides to weakest level of year after Trump tariff https://seekingalpha.com/news/3259392-loonie-slides-to-weakest-level-of-year-after-trump-tariff?source=tweet\" data-url=\"https://seekingalpha.com/news/3259392-loonie-slides-to-weakest-level-of-year-after-trump-tariff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259390\" data-ts=\"1493127504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259390-best-buy-rides-baml-upgrade-to-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Best Buy rides BAML upgrade to 52-week high</a></h4><ul> <li>Bank of America Merrill Lynch upgrades Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co.'>BBY</a> <font color='green'>+2.3%</font>) to a Buy rating.</li> <li>The investment firm sets a price target of $58.</li> <li>Shares of Best Buy sailed to a new 52-week high of $52.58 off the BAML vote of confidence.</li> <li>Best Buy is due to report earnings on May 23.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259390\" data-linked=\"Best Buy rides BAML upgrade to 52-week high\" data-tweet=\"$BBY - Best Buy rides BAML upgrade to 52-week high https://seekingalpha.com/news/3259390-best-buy-rides-baml-upgrade-to-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3259390-best-buy-rides-baml-upgrade-to-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259387\" data-ts=\"1493127272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259387-wells-fargo-annual-meeting-to-start-board-to-be-re-elected-says-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo annual meeting about to start; board to be re-elected, says WSJ</a></h4><ul><li>The annual meeting officially begins at 10 ET. <a href=\"https://www.wellsfargo.com/about/investor-relations/events/\" target=\"_blank\">Live webcast here</a>.</li><li>The votes are still coming in, but the <em>WSJ</em> says the board is likely to be re-elected in a close vote, with support for some members likely to be uncomfortably low.</li><li>In other news, Guggenheim this morning upgraded Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color='green'>+1.6%</font>) to Neutral. Analyst Eric Wasserstrom remains cautious, citing the risk of a&nbsp;qualitative failure in this year's CCAR.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259387\" data-linked=\"Wells Fargo annual meeting about to start; board to be re-elected, says WSJ\" data-tweet=\"$WFC - Wells Fargo annual meeting about to start; board to be re-elected, says WSJ https://seekingalpha.com/news/3259387-wells-fargo-annual-meeting-to-start-board-to-be-re-elected-says-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3259387-wells-fargo-annual-meeting-to-start-board-to-be-re-elected-says-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259386\" data-ts=\"1493127171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259386-tyson-foods-to-sell-dessert-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson Foods to sell dessert assets</a></h4><ul> <li>Tyson Foods (<a href='https://seekingalpha.com/symbol/TSN' title='Tyson Foods Inc.'>TSN</a> <font color='green'>+1.9%</font>) discloses that it started the process of looking to divest its Sara Lee frozen bakery, Kettle and Van&rsquo;s businesses.</li> <li>\"The businesses we&rsquo;re exploring to sell include well-respected brands, operations and product lines,\" says CEo Tom Hayes.</li> <li>\"With our protein-focused strategy, we believe other companies may be better positioned to unlock their value over time,\" he adds.</li><li>Earlier today, Tyson made a strong protein move with the acquisition of AdvancePierre Foods.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3259282-tyson-foods-acquires-advancepierre-foods\" target=\"_blank\">Tyson Foods acquires AdvancePierre Foods</a> (April 25)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3259386\" data-linked=\"Tyson Foods to sell dessert assets\" data-tweet=\"$TSN - Tyson Foods to sell dessert assets https://seekingalpha.com/news/3259386-tyson-foods-to-sell-dessert-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3259386-tyson-foods-to-sell-dessert-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259377\" data-ts=\"1493126806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QURE\" target=\"_blank\">QURE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259377-ema-designates-uniqures-gene-therapy-for-hemophilia-b-for-accelerated-review-shares-ahead-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EMA designates uniQure&#39;s gene therapy for hemophilia B for accelerated review; shares ahead 9% premarket</a></h4><ul><li>UniQure (NASDAQ:<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;premarket on average volume in response to its announcement that the European Medicines Agency &#40;EMA&#41; has <a href=\"https://seekingalpha.com/pr/16808688-uniqure-receives-european-medicines-agency-priority-medicines-prime-designation-amtminus-060\" target=\"_blank\">designated</a>&nbsp;hemophilia B candidate AMT-060 for PRIME status, allowing for more intensive regulatory guidance in development and accelerated review of the Marketing Authorization Application &#40;MAA&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259377\" data-linked=\"EMA designates uniQure&#39;s gene therapy for hemophilia B for accelerated review; shares ahead 9% premarket\" data-tweet=\"$QURE - EMA designates uniQure&#39;s gene therapy for hemophilia B for accelerated review; shares ahead 9% premarket https://seekingalpha.com/news/3259377-ema-designates-uniqures-gene-therapy-for-hemophilia-b-for-accelerated-review-shares-ahead-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3259377-ema-designates-uniqures-gene-therapy-for-hemophilia-b-for-accelerated-review-shares-ahead-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259375\" data-ts=\"1493126720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRP\" target=\"_blank\">STRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259375-straight-pathplus-8_2-new-bidder-tops-and-t-buyout-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Straight Path +8.2% as new bidder tops AT&amp;T buyout deal</a></h4><ul>   <li>Straight Path Communications (NYSEMKT:<a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a>) is on the move again, <font color='green'>up 8.2%</font> premarket, after saying it's gotten an unsolicited offer that <a href=\"https://seekingalpha.com/pr/16808586-straight-path-board-determines-unsolicited-offer-multi-national-telecommunications-company\" target=\"_blank\">constitutes a \"superior proposal\"</a> to its agreement to be acquired by AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>).</li>    <li>\"A multinational telecommunications company\" -- <a href=\"https://seekingalpha.com/news/3257176-straight-path-plus-3_6-percent-word-possible-verizon-bid\" target=\"_blank\">all indications are that that's Verizon</a> (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) -- has offered to acquire Straight Path for $104.64/share, an enterprise value of $1.8B, in an all-stock deal. That's vs. AT&amp;T's offer of $95.63/share.</li>    <li>Premarket quotes at $120 are well above even the new bid of $104.64, suggesting investors are looking toward a bidding war for Straight Path and its valuable millimeter wave spectrum.</li>    <li>Straight Path notified AT&amp;T, which has five business days to match or exceed the new bid.</li>    <li>If the AT&amp;T deal is terminated, Straight Path would owe AT&amp;T a $38M termination fee, but the new bidder has agreed to pay that fee on Straight Path's behalf.</li>    <li>The new bidder's offer is outstanding until 11:59 p.m. ET on May 3.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259375\" data-linked=\"Straight Path +8.2% as new bidder tops AT&amp;T buyout deal\" data-tweet=\"$STRP $STRP $T - Straight Path +8.2% as new bidder tops AT&amp;T buyout deal https://seekingalpha.com/news/3259375-straight-pathplus-8_2-new-bidder-tops-and-t-buyout-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3259375-straight-pathplus-8_2-new-bidder-tops-and-t-buyout-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259374\" data-ts=\"1493126716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259374-alcoaplus-4-on-q1-earnings-beat-upbeat-aluminum-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa +4% on Q1 earnings beat, upbeat aluminum outlook</a></h4><ul>     <li>Alcoa (NYSE:<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a>) <font color='green'>+4.1%</font> premarket after easily beating <a href=\"https://seekingalpha.com/news/3259069-alcoa-beats-0_10-misses-revenue\" target=\"_blank\">Q1 earnings</a> expectations in its first full quarter as a stand-alone company.</li><li>AA says Q1 profits grew sequentially on stronger alumina and aluminum pricing, and reports a 59% Q/Q gain in adjusted EBITDA of $533M.</li>     <li>AA reiterates expectations for FY 2017 adjusted EBITDA of $2.1B-$2.3B and projects 2017 global aluminum demand growth of 4.5%-5% Y/Y, up from its January outlook for 4% growth.</li>     <li>The company continues to see relatively balanced global bauxite and alumina markets  and a global aluminum surplus of 300K-700K metric tons.</li><li>AA will be \"very aggressive on cost-cutting,&rdquo; analyst Lloyd O&rsquo;Carroll tells Bloomberg, and &ldquo;<a href=\"https://www.bloomberg.com/news/articles/2017-04-24/alcoa-earnings-sizzle-brings-new-life-to-party-after-share-surge\" target=\"_blank\">can move a lot faster</a>&rdquo; since the Arconic spinoff.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259374\" data-linked=\"Alcoa +4% on Q1 earnings beat, upbeat aluminum outlook\" data-tweet=\"$AA - Alcoa +4% on Q1 earnings beat, upbeat aluminum outlook https://seekingalpha.com/news/3259374-alcoaplus-4-on-q1-earnings-beat-upbeat-aluminum-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3259374-alcoaplus-4-on-q1-earnings-beat-upbeat-aluminum-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259372\" data-ts=\"1493126592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259372-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='green'>+27%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16808829-catabasis-pharmaceuticals-announces-favorable-results-functional-assessments-movedmd-trial\" target=\"_blank\">announcing</a> additional favorable results across multiple functional assessments in the MoveDMD trial.</li><li><a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+23%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16808655-can-fites-phase-iii-acrobat-trial-rheumatoid-arthritis-approved-institutional-review-board\" target=\"_blank\">announcing</a> that&nbsp;<a href=\"http://www.barzilaimc.org.il/eng\" target=\"_blank\">Barzilai Medical Center</a>'s Institutional Review Board has approved the Phase III ACRobat trial protocol and patient enrollment for the study at the 627-bed hospital in&nbsp;Ashkelon, Israel.</li><li><a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='green'>+16%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16808427-servier-cti-biopharma-expand-license-collaboration-agreement-develop-commercialize-pixuvri\" target=\"_blank\">agreeing</a> to expand their existing license and development collaboration agreement for PIXUVRI.</li><li><a href='https://seekingalpha.com/symbol/UIS' title='Unisys Corporation'>UIS</a> <font color='green'>+14%</font>.</li><li><a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='green'>+12% on&nbsp;</font><a href=\"https://seekingalpha.com/pr/16808533-capricor-therapeutics-announces-positive-six-month-results-randomized-phase-ii-hope-clinical\" target=\"_blank\">announcing</a> positive top-line results from a safety and exploratory efficacy analysis of six-month data from the randomized 12-month Phase I/II HOPE Clinical Trial of CAP-1002.</li><li><a href='https://seekingalpha.com/symbol/LLNW' title='Limelight Networks, Inc.'>LLNW</a> <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/symbol/APFH' title='AdvancePierre Foods Holdings'>APFH</a> <font color='green'>+9%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3249866-advancepierre-foods-beats-0_01-misses-revenue\" target=\"_blank\">earnings</a> beat.</li><li><a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a> <font color='green'>+9%.</font></li><li><a href='https://seekingalpha.com/symbol/STRP' title='Straight Path Communications Inc.'>STRP</a> <font color='green'>+8%&nbsp;</font>on an unsolicited&nbsp;<a href=\"https://seekingalpha.com/pr/16808586-straight-path-board-determines-unsolicited-offer-multi-national-telecommunications-company\" target=\"_blank\">offer</a>&nbsp;from a multi-national telecommunications company to acquire 100% of the issued and outstanding shares of Straight Path for $104.64 per share.</li><li><a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='green'>+8%&nbsp;</font>on Q1 <a href=\"https://seekingalpha.com/news/3259214-supervalu-beats-0_04-beats-revenue\" target=\"_blank\">earnings</a> beat.</li><li><a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a> <font color='green'>+7%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3259275-mcdermott-beats-0_07-misses-revenue\" target=\"_blank\">earnings</a> beat.</li><li><a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='green'>+6%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3259271-caterpillar-beats-0_66-beats-revenue\" target=\"_blank\">earnings</a> beat</li><li><a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+5%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3259329-ak-steel-beats-0_04-beats-revenue\" target=\"_blank\">earnings</a> beat.</li><li><a href='https://seekingalpha.com/symbol/TGTX' title='TG Therapeutics, Inc.'>TGTX</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3259372\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$CATB $CANF $CTIC - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3259372-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3259372-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259371\" data-ts=\"1493126249\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXE\" target=\"_blank\">AXE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259371-on-anixters-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Anixter&#39;s Q1</a></h4><ul>     <li>Anixter (NYSE:<a href='https://seekingalpha.com/symbol/AXE' title='Anixter International Inc.'>AXE</a>) reports organic net sales rose 4% in <a href=\"https://seekingalpha.com/pr/16808570-anixter-international-inc-reports-first-quarter-2017-results\" target=\"_blank\">Q1</a>.</li>     <li>Network &amp; Security Solutions net sales up 3.8% to $984.9M.</li>     <li>Electrical &amp; Electronic Solutions net sales expanded 4.2% to $527.4M.</li>     <li>Utility Power Solutions net sales advanced 6.2% to $383.5M.</li>     <li>North America net sales increased 3.6% to $1.57B.</li>     <li>Gross margin rate slipped 40 bps to 20%.</li>     <li>Adjusted operating margin rate grew 10 bps to 4.1%.</li>     <li>Adjusted EBITDA margin +10 bps to 4.7%.</li>     <li>The company expects Q2 organic sales growth in the 1.5% - 3% range.</li>     <li><b>FY2017 Guidance</b>: Organic sales: +2% to +4%; Cash flow from operation: $200M to $220M; Capex: $40M to $50M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3259371\" data-linked=\"More on Anixter&#39;s Q1\" data-tweet=\"$AXE - More on Anixter&#39;s Q1 https://seekingalpha.com/news/3259371-on-anixters-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3259371-on-anixters-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259369\" data-ts=\"1493126111\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259369-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='red'>-25%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16809213-contravir-pharmaceuticals-announces-pricing-public-offering-common-stock-warrants\" target=\"_blank\">announcing</a> pricing of equity offering.</li><li><a href='https://seekingalpha.com/symbol/PZRX' title='PhaseRx'>PZRX</a> <font color='red'>-17%</font>&nbsp;on PhaseRX <a href=\"https://seekingalpha.com/pr/16808992-phaserx-receives-positive-opinion-orphan-drug-designation-prx-otc-european-medicines-agency\" target=\"_blank\">receiving</a> Orphan Drug designation by EMA.</li><li><a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a> <font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3259289-ngl-energy-partners-cuts-2017-guidance-minus-10_6-percent-premarket\" target=\"_blank\">lowering</a> FY2017 guidance.</li><li><a href='https://seekingalpha.com/symbol/ESRX' title='Express Scripts, Inc.'>ESRX</a> <font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3259050-express-scripts-beats-0_01-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/EAT' title='Brinker International, Inc.'>EAT</a> <font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3259255-brinker-beats-0_09-misses-revenue\" target=\"_blank\">Q3 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3259369\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$HEPA $PZRX $NGL - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3259369-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3259369-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3259366\" data-ts=\"1493125736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CATB\" target=\"_blank\">CATB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3259366-catabasis-pharmas-edasalonexent-slows-rate-of-functional-decline-in-dmd-boys-in-mid-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catabasis Pharma&#39;s edasalonexent slows rate of functional decline in DMD boys in mid-stage study; shares ahead 29% premarket</a></h4><ul><li>Nano cap Catabasis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a>) is up&nbsp;<font color='green'>29%</font>&nbsp;premarket on robust volume in response to the <a href=\"https://seekingalpha.com/pr/16808829-catabasis-pharmaceuticals-announces-favorable-results-functional-assessments-movedmd-trial\" target=\"_blank\">presentation</a> of data from Part B of its Phase 2 clinical trial, MoveDMD, assessing edasalonexent in boys with Duchenne muscular dystrophy &#40;DMD&#41;. The results were announced at the American Academy of Neurology 69th Annual Meeting in Boston.</li><li>In January, the company reported that MoveDMD failed to show a treatment benefit over placebo. The functional data presented at AAN show a numerical improvement, but none are statistically significant since the study was not powered to demonstrate it for these parameters.</li><li>DMD boys treated with edasalonexent for 12 weeks experienced a 50% slower rate of decline in the 10-meter walk/run test, a 45% slower rate of decline in time to stand and more than 50% reductions in the rates of decline in the 4-stair climb, North Star Ambulatory Assessment and Pediatric Outcomes Data Collection Instrument assessment.</li><li>The company plans to report interim results from the open-label extension phase (Part C) of MoveDMD next quarter. It will determine the next development steps after completing additional data analyses.</li><li>Edasalonexent inhibits a protein activated in DMD called NF-kB which plays a key role in inflammation and fibrosis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3239301-catabasis-pharmas-edasalonexent-flops-randomized-portion-mid-stage-dmd-study-shares-crater-58\" target=\"_blank\">Catabasis Pharma's edasalonexent flops in randomized portion of mid-stage DMD study; shares crater 58% after hours</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3259366\" data-linked=\"Catabasis Pharma&#39;s edasalonexent slows rate of functional decline in DMD boys in mid-stage study; shares ahead 29% premarket\" data-tweet=\"$CATB - Catabasis Pharma&#39;s edasalonexent slows rate of functional decline in DMD boys in mid-stage study; shares ahead 29% premarket https://seekingalpha.com/news/3259366-catabasis-pharmas-edasalonexent-slows-rate-of-functional-decline-in-dmd-boys-in-mid-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3259366-catabasis-pharmas-edasalonexent-slows-rate-of-functional-decline-in-dmd-boys-in-mid-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}